TWI399221B - 含有迷迭香萃取物之口腔組成物及相關方法 - Google Patents
含有迷迭香萃取物之口腔組成物及相關方法 Download PDFInfo
- Publication number
- TWI399221B TWI399221B TW094144587A TW94144587A TWI399221B TW I399221 B TWI399221 B TW I399221B TW 094144587 A TW094144587 A TW 094144587A TW 94144587 A TW94144587 A TW 94144587A TW I399221 B TWI399221 B TW I399221B
- Authority
- TW
- Taiwan
- Prior art keywords
- composition
- weight
- acid
- rosemary extract
- triclosan
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title claims description 146
- 239000000284 extract Substances 0.000 title claims description 11
- 241001529742 Rosmarinus Species 0.000 title claims 2
- 238000000034 method Methods 0.000 title description 4
- QRYRORQUOLYVBU-VBKZILBWSA-N carnosic acid Chemical compound CC([C@@H]1CC2)(C)CCC[C@]1(C(O)=O)C1=C2C=C(C(C)C)C(O)=C1O QRYRORQUOLYVBU-VBKZILBWSA-N 0.000 claims description 58
- 235000020748 rosemary extract Nutrition 0.000 claims description 46
- 229940092258 rosemary extract Drugs 0.000 claims description 44
- 239000001233 rosmarinus officinalis l. extract Substances 0.000 claims description 44
- 239000000551 dentifrice Substances 0.000 claims description 23
- 229940096998 ursolic acid Drugs 0.000 claims description 23
- PLSAJKYPRJGMHO-UHFFFAOYSA-N ursolic acid Natural products CC1CCC2(CCC3(C)C(C=CC4C5(C)CCC(O)C(C)(C)C5CCC34C)C2C1C)C(=O)O PLSAJKYPRJGMHO-UHFFFAOYSA-N 0.000 claims description 23
- WCGUUGGRBIKTOS-GPOJBZKASA-N (3beta)-3-hydroxyurs-12-en-28-oic acid Chemical compound C1C[C@H](O)C(C)(C)[C@@H]2CC[C@@]3(C)[C@]4(C)CC[C@@]5(C(O)=O)CC[C@@H](C)[C@H](C)[C@H]5C4=CC[C@@H]3[C@]21C WCGUUGGRBIKTOS-GPOJBZKASA-N 0.000 claims description 22
- 239000002324 mouth wash Substances 0.000 claims description 22
- 239000000606 toothpaste Substances 0.000 claims description 20
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 19
- 229940034610 toothpaste Drugs 0.000 claims description 19
- 229960003500 triclosan Drugs 0.000 claims description 19
- 229940051866 mouthwash Drugs 0.000 claims description 17
- XEFQLINVKFYRCS-UHFFFAOYSA-N Triclosan Chemical compound OC1=CC(Cl)=CC=C1OC1=CC=C(Cl)C=C1Cl XEFQLINVKFYRCS-UHFFFAOYSA-N 0.000 claims description 16
- 229920000642 polymer Polymers 0.000 claims description 15
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims description 14
- 230000000844 anti-bacterial effect Effects 0.000 claims description 14
- 239000003205 fragrance Substances 0.000 claims description 14
- 239000004615 ingredient Substances 0.000 claims description 12
- 235000015218 chewing gum Nutrition 0.000 claims description 10
- 239000003906 humectant Substances 0.000 claims description 10
- 125000000129 anionic group Chemical group 0.000 claims description 9
- 229940112822 chewing gum Drugs 0.000 claims description 8
- 229920005646 polycarboxylate Polymers 0.000 claims description 8
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 8
- 150000001875 compounds Chemical class 0.000 claims description 6
- 235000011187 glycerol Nutrition 0.000 claims description 6
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 claims description 5
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 claims description 5
- 239000003242 anti bacterial agent Substances 0.000 claims description 5
- 239000004075 cariostatic agent Substances 0.000 claims description 5
- 239000000600 sorbitol Substances 0.000 claims description 5
- 239000000080 wetting agent Substances 0.000 claims description 5
- 239000000126 substance Substances 0.000 claims description 3
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 claims 6
- YCKRFDGAMUMZLT-UHFFFAOYSA-N Fluorine atom Chemical compound [F] YCKRFDGAMUMZLT-UHFFFAOYSA-N 0.000 claims 1
- 229910052731 fluorine Inorganic materials 0.000 claims 1
- 239000011737 fluorine Substances 0.000 claims 1
- 150000002483 hydrogen compounds Chemical class 0.000 claims 1
- -1 halogenated diphenyl ether compound Chemical class 0.000 description 37
- 239000003795 chemical substances by application Substances 0.000 description 32
- 230000002272 anti-calculus Effects 0.000 description 16
- 244000178231 Rosmarinus officinalis Species 0.000 description 13
- 230000000845 anti-microbial effect Effects 0.000 description 13
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 12
- USIUVYZYUHIAEV-UHFFFAOYSA-N diphenyl ether Chemical class C=1C=CC=CC=1OC1=CC=CC=C1 USIUVYZYUHIAEV-UHFFFAOYSA-N 0.000 description 12
- 230000003078 antioxidant effect Effects 0.000 description 11
- 230000003110 anti-inflammatory effect Effects 0.000 description 10
- 239000000499 gel Substances 0.000 description 10
- 150000003839 salts Chemical class 0.000 description 10
- 239000004599 antimicrobial Substances 0.000 description 9
- 239000002253 acid Substances 0.000 description 8
- 230000002882 anti-plaque Effects 0.000 description 8
- FQENQNTWSFEDLI-UHFFFAOYSA-J sodium diphosphate Chemical compound [Na+].[Na+].[Na+].[Na+].[O-]P([O-])(=O)OP([O-])([O-])=O FQENQNTWSFEDLI-UHFFFAOYSA-J 0.000 description 8
- 235000019832 sodium triphosphate Nutrition 0.000 description 8
- 235000019818 tetrasodium diphosphate Nutrition 0.000 description 8
- 229920001577 copolymer Polymers 0.000 description 7
- 230000000694 effects Effects 0.000 description 7
- 235000003599 food sweetener Nutrition 0.000 description 7
- 239000004094 surface-active agent Substances 0.000 description 7
- 239000003765 sweetening agent Substances 0.000 description 7
- 230000001225 therapeutic effect Effects 0.000 description 7
- DOUMFZQKYFQNTF-WUTVXBCWSA-N (R)-rosmarinic acid Chemical compound C([C@H](C(=O)O)OC(=O)\C=C\C=1C=C(O)C(O)=CC=1)C1=CC=C(O)C(O)=C1 DOUMFZQKYFQNTF-WUTVXBCWSA-N 0.000 description 6
- 108090000790 Enzymes Proteins 0.000 description 6
- 102000004190 Enzymes Human genes 0.000 description 6
- 229910019142 PO4 Inorganic materials 0.000 description 6
- XLOMVQKBTHCTTD-UHFFFAOYSA-N Zinc monoxide Chemical compound [Zn]=O XLOMVQKBTHCTTD-UHFFFAOYSA-N 0.000 description 6
- 239000003082 abrasive agent Substances 0.000 description 6
- 229940088598 enzyme Drugs 0.000 description 6
- 238000001727 in vivo Methods 0.000 description 6
- 235000021317 phosphate Nutrition 0.000 description 6
- PUZPDOWCWNUUKD-UHFFFAOYSA-M sodium fluoride Chemical compound [F-].[Na+] PUZPDOWCWNUUKD-UHFFFAOYSA-M 0.000 description 6
- 241000196324 Embryophyta Species 0.000 description 5
- KRHYYFGTRYWZRS-UHFFFAOYSA-M Fluoride anion Chemical compound [F-] KRHYYFGTRYWZRS-UHFFFAOYSA-M 0.000 description 5
- 241001465754 Metazoa Species 0.000 description 5
- 239000003963 antioxidant agent Substances 0.000 description 5
- 235000006708 antioxidants Nutrition 0.000 description 5
- 239000002585 base Substances 0.000 description 5
- 150000007942 carboxylates Chemical class 0.000 description 5
- 239000003086 colorant Substances 0.000 description 5
- 208000007565 gingivitis Diseases 0.000 description 5
- 238000000338 in vitro Methods 0.000 description 5
- FPYJFEHAWHCUMM-UHFFFAOYSA-N maleic anhydride Chemical compound O=C1OC(=O)C=C1 FPYJFEHAWHCUMM-UHFFFAOYSA-N 0.000 description 5
- OSWPMRLSEDHDFF-UHFFFAOYSA-N methyl salicylate Chemical compound COC(=O)C1=CC=CC=C1O OSWPMRLSEDHDFF-UHFFFAOYSA-N 0.000 description 5
- 210000000214 mouth Anatomy 0.000 description 5
- 229920001223 polyethylene glycol Polymers 0.000 description 5
- 239000010455 vermiculite Substances 0.000 description 5
- 229910052902 vermiculite Inorganic materials 0.000 description 5
- 235000019354 vermiculite Nutrition 0.000 description 5
- MIJYXULNPSFWEK-GTOFXWBISA-N 3beta-hydroxyolean-12-en-28-oic acid Chemical compound C1C[C@H](O)C(C)(C)[C@@H]2CC[C@@]3(C)[C@]4(C)CC[C@@]5(C(O)=O)CCC(C)(C)C[C@H]5C4=CC[C@@H]3[C@]21C MIJYXULNPSFWEK-GTOFXWBISA-N 0.000 description 4
- BVKZGUZCCUSVTD-UHFFFAOYSA-M Bicarbonate Chemical class OC([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-M 0.000 description 4
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 4
- JKLISIRFYWXLQG-UHFFFAOYSA-N Epioleonolsaeure Natural products C1CC(O)C(C)(C)C2CCC3(C)C4(C)CCC5(C(O)=O)CCC(C)(C)CC5C4CCC3C21C JKLISIRFYWXLQG-UHFFFAOYSA-N 0.000 description 4
- YBRJHZPWOMJYKQ-UHFFFAOYSA-N Oleanolic acid Natural products CC1(C)CC2C3=CCC4C5(C)CCC(O)C(C)(C)C5CCC4(C)C3(C)CCC2(C1)C(=O)O YBRJHZPWOMJYKQ-UHFFFAOYSA-N 0.000 description 4
- MIJYXULNPSFWEK-UHFFFAOYSA-N Oleanolinsaeure Natural products C1CC(O)C(C)(C)C2CCC3(C)C4(C)CCC5(C(O)=O)CCC(C)(C)CC5C4=CCC3C21C MIJYXULNPSFWEK-UHFFFAOYSA-N 0.000 description 4
- MUBZPKHOEPUJKR-UHFFFAOYSA-N Oxalic acid Chemical compound OC(=O)C(O)=O MUBZPKHOEPUJKR-UHFFFAOYSA-N 0.000 description 4
- PTFCDOFLOPIGGS-UHFFFAOYSA-N Zinc dication Chemical compound [Zn+2] PTFCDOFLOPIGGS-UHFFFAOYSA-N 0.000 description 4
- 150000001412 amines Chemical class 0.000 description 4
- 239000006260 foam Substances 0.000 description 4
- LHGVFZTZFXWLCP-UHFFFAOYSA-N guaiacol Chemical compound COC1=CC=CC=C1O LHGVFZTZFXWLCP-UHFFFAOYSA-N 0.000 description 4
- CGIGDMFJXJATDK-UHFFFAOYSA-N indomethacin Chemical compound CC1=C(CC(O)=O)C2=CC(OC)=CC=C2N1C(=O)C1=CC=C(Cl)C=C1 CGIGDMFJXJATDK-UHFFFAOYSA-N 0.000 description 4
- 239000013642 negative control Substances 0.000 description 4
- FHHSEFRSDKWJKJ-UHFFFAOYSA-N nepetin Chemical compound C=1C(=O)C2=C(O)C(OC)=C(O)C=C2OC=1C1=CC=C(O)C(O)=C1 FHHSEFRSDKWJKJ-UHFFFAOYSA-N 0.000 description 4
- 229910052757 nitrogen Inorganic materials 0.000 description 4
- 229940100243 oleanolic acid Drugs 0.000 description 4
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N phenol group Chemical group C1(=CC=CC=C1)O ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 4
- 150000002989 phenols Chemical class 0.000 description 4
- 150000003013 phosphoric acid derivatives Chemical class 0.000 description 4
- 239000000047 product Substances 0.000 description 4
- HZLWUYJLOIAQFC-UHFFFAOYSA-N prosapogenin PS-A Natural products C12CC(C)(C)CCC2(C(O)=O)CCC(C2(CCC3C4(C)C)C)(C)C1=CCC2C3(C)CCC4OC1OCC(O)C(O)C1O HZLWUYJLOIAQFC-UHFFFAOYSA-N 0.000 description 4
- 239000002562 thickening agent Substances 0.000 description 4
- MGSRCZKZVOBKFT-UHFFFAOYSA-N thymol Chemical compound CC(C)C1=CC=C(C)C=C1O MGSRCZKZVOBKFT-UHFFFAOYSA-N 0.000 description 4
- NOOLISFMXDJSKH-UTLUCORTSA-N (+)-Neomenthol Chemical compound CC(C)[C@@H]1CC[C@@H](C)C[C@@H]1O NOOLISFMXDJSKH-UTLUCORTSA-N 0.000 description 3
- WEEGYLXZBRQIMU-UHFFFAOYSA-N 1,8-cineole Natural products C1CC2CCC1(C)OC2(C)C WEEGYLXZBRQIMU-UHFFFAOYSA-N 0.000 description 3
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 3
- NOOLISFMXDJSKH-UHFFFAOYSA-N DL-menthol Natural products CC(C)C1CCC(C)CC1O NOOLISFMXDJSKH-UHFFFAOYSA-N 0.000 description 3
- WEEGYLXZBRQIMU-WAAGHKOSSA-N Eucalyptol Chemical compound C1C[C@H]2CC[C@]1(C)OC2(C)C WEEGYLXZBRQIMU-WAAGHKOSSA-N 0.000 description 3
- ZZAFFYPNLYCDEP-HNNXBMFYSA-N Rosmarinsaeure Natural products OC(=O)[C@H](Cc1cccc(O)c1O)OC(=O)C=Cc2ccc(O)c(O)c2 ZZAFFYPNLYCDEP-HNNXBMFYSA-N 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 229920002125 Sokalan® Polymers 0.000 description 3
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 3
- WHMDKBIGKVEYHS-IYEMJOQQSA-L Zinc gluconate Chemical compound [Zn+2].OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O.OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O WHMDKBIGKVEYHS-IYEMJOQQSA-L 0.000 description 3
- 229910052783 alkali metal Inorganic materials 0.000 description 3
- 229940121363 anti-inflammatory agent Drugs 0.000 description 3
- 239000002260 anti-inflammatory agent Substances 0.000 description 3
- 239000008376 breath freshener Substances 0.000 description 3
- 229960001927 cetylpyridinium chloride Drugs 0.000 description 3
- YMKDRGPMQRFJGP-UHFFFAOYSA-M cetylpyridinium chloride Chemical compound [Cl-].CCCCCCCCCCCCCCCC[N+]1=CC=CC=C1 YMKDRGPMQRFJGP-UHFFFAOYSA-M 0.000 description 3
- 229960005233 cineole Drugs 0.000 description 3
- 235000011180 diphosphates Nutrition 0.000 description 3
- 235000013399 edible fruits Nutrition 0.000 description 3
- 229920001971 elastomer Polymers 0.000 description 3
- 238000000605 extraction Methods 0.000 description 3
- RAXXELZNTBOGNW-UHFFFAOYSA-N imidazole Natural products C1=CNC=N1 RAXXELZNTBOGNW-UHFFFAOYSA-N 0.000 description 3
- 239000007788 liquid Substances 0.000 description 3
- 229940041616 menthol Drugs 0.000 description 3
- 229920003052 natural elastomer Polymers 0.000 description 3
- 229920001194 natural rubber Polymers 0.000 description 3
- 239000003921 oil Substances 0.000 description 3
- 235000019198 oils Nutrition 0.000 description 3
- 230000009467 reduction Effects 0.000 description 3
- DOUMFZQKYFQNTF-MRXNPFEDSA-N rosemarinic acid Natural products C([C@H](C(=O)O)OC(=O)C=CC=1C=C(O)C(O)=CC=1)C1=CC=C(O)C(O)=C1 DOUMFZQKYFQNTF-MRXNPFEDSA-N 0.000 description 3
- 239000010668 rosemary oil Substances 0.000 description 3
- 229940058206 rosemary oil Drugs 0.000 description 3
- TVHVQJFBWRLYOD-UHFFFAOYSA-N rosmarinic acid Natural products OC(=O)C(Cc1ccc(O)c(O)c1)OC(=Cc2ccc(O)c(O)c2)C=O TVHVQJFBWRLYOD-UHFFFAOYSA-N 0.000 description 3
- 239000011734 sodium Substances 0.000 description 3
- 229910052708 sodium Inorganic materials 0.000 description 3
- 239000011775 sodium fluoride Substances 0.000 description 3
- 235000013024 sodium fluoride Nutrition 0.000 description 3
- 239000001488 sodium phosphate Substances 0.000 description 3
- 235000010356 sorbitol Nutrition 0.000 description 3
- 229910001432 tin ion Inorganic materials 0.000 description 3
- 229940088594 vitamin Drugs 0.000 description 3
- 229930003231 vitamin Natural products 0.000 description 3
- 235000013343 vitamin Nutrition 0.000 description 3
- 239000011782 vitamin Substances 0.000 description 3
- 230000002087 whitening effect Effects 0.000 description 3
- 239000011670 zinc gluconate Substances 0.000 description 3
- 235000011478 zinc gluconate Nutrition 0.000 description 3
- 229960000306 zinc gluconate Drugs 0.000 description 3
- 239000011787 zinc oxide Substances 0.000 description 3
- XHXUANMFYXWVNG-ADEWGFFLSA-N (-)-Menthyl acetate Chemical compound CC(C)[C@@H]1CC[C@@H](C)C[C@H]1OC(C)=O XHXUANMFYXWVNG-ADEWGFFLSA-N 0.000 description 2
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 2
- NIXOWILDQLNWCW-UHFFFAOYSA-N 2-Propenoic acid Natural products OC(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 description 2
- FJKROLUGYXJWQN-UHFFFAOYSA-M 4-hydroxybenzoate Chemical compound OC1=CC=C(C([O-])=O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-M 0.000 description 2
- UZQWHZRLSLEWHW-UHFFFAOYSA-N 6-methoxyluteolin Natural products C1C(=O)C2=C(O)C(OC)=C(O)C=C2OC1C1=CC=C(O)C(O)=C1 UZQWHZRLSLEWHW-UHFFFAOYSA-N 0.000 description 2
- QGZKDVFQNNGYKY-UHFFFAOYSA-O Ammonium Chemical group [NH4+] QGZKDVFQNNGYKY-UHFFFAOYSA-O 0.000 description 2
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- 108010011485 Aspartame Proteins 0.000 description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 2
- XUSYGBPHQBWGAD-PJSUUKDQSA-N Carnosol Chemical compound CC([C@@H]1C2)(C)CCC[C@@]11C(=O)O[C@@H]2C2=C1C(O)=C(O)C(C(C)C)=C2 XUSYGBPHQBWGAD-PJSUUKDQSA-N 0.000 description 2
- MMFRMKXYTWBMOM-UHFFFAOYSA-N Carnosol Natural products CCc1cc2C3CC4C(C)(C)CCCC4(C(=O)O3)c2c(O)c1O MMFRMKXYTWBMOM-UHFFFAOYSA-N 0.000 description 2
- KRKNYBCHXYNGOX-UHFFFAOYSA-K Citrate Chemical compound [O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O KRKNYBCHXYNGOX-UHFFFAOYSA-K 0.000 description 2
- 235000005979 Citrus limon Nutrition 0.000 description 2
- 244000131522 Citrus pyriformis Species 0.000 description 2
- 235000013162 Cocos nucifera Nutrition 0.000 description 2
- 244000060011 Cocos nucifera Species 0.000 description 2
- SRBFZHDQGSBBOR-IOVATXLUSA-N D-xylopyranose Chemical compound O[C@@H]1COC(O)[C@H](O)[C@H]1O SRBFZHDQGSBBOR-IOVATXLUSA-N 0.000 description 2
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 2
- DBVJJBKOTRCVKF-UHFFFAOYSA-N Etidronic acid Chemical compound OP(=O)(O)C(O)(C)P(O)(O)=O DBVJJBKOTRCVKF-UHFFFAOYSA-N 0.000 description 2
- 241000282326 Felis catus Species 0.000 description 2
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 2
- VZCYOOQTPOCHFL-OWOJBTEDSA-N Fumaric acid Chemical compound OC(=O)\C=C\C(O)=O VZCYOOQTPOCHFL-OWOJBTEDSA-N 0.000 description 2
- 244000043261 Hevea brasiliensis Species 0.000 description 2
- OAKJQQAXSVQMHS-UHFFFAOYSA-N Hydrazine Chemical compound NN OAKJQQAXSVQMHS-UHFFFAOYSA-N 0.000 description 2
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 2
- OFOBLEOULBTSOW-UHFFFAOYSA-N Malonic acid Chemical compound OC(=O)CC(O)=O OFOBLEOULBTSOW-UHFFFAOYSA-N 0.000 description 2
- XYFCBTPGUUZFHI-UHFFFAOYSA-N Phosphine Chemical compound P XYFCBTPGUUZFHI-UHFFFAOYSA-N 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 2
- 229920000388 Polyphosphate Polymers 0.000 description 2
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 2
- 239000005844 Thymol Substances 0.000 description 2
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 description 2
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 2
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 description 2
- 240000008042 Zea mays Species 0.000 description 2
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 2
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 2
- DHKHKXVYLBGOIT-UHFFFAOYSA-N acetaldehyde Diethyl Acetal Natural products CCOC(C)OCC DHKHKXVYLBGOIT-UHFFFAOYSA-N 0.000 description 2
- ZOIORXHNWRGPMV-UHFFFAOYSA-N acetic acid;zinc Chemical compound [Zn].CC(O)=O.CC(O)=O ZOIORXHNWRGPMV-UHFFFAOYSA-N 0.000 description 2
- 239000004480 active ingredient Substances 0.000 description 2
- 239000013543 active substance Substances 0.000 description 2
- 230000003113 alkalizing effect Effects 0.000 description 2
- RDOXTESZEPMUJZ-UHFFFAOYSA-N anisole Chemical compound COC1=CC=CC=C1 RDOXTESZEPMUJZ-UHFFFAOYSA-N 0.000 description 2
- 230000000181 anti-adherent effect Effects 0.000 description 2
- 230000003610 anti-gingivitis Effects 0.000 description 2
- 239000003911 antiadherent Substances 0.000 description 2
- 239000000605 aspartame Substances 0.000 description 2
- IAOZJIPTCAWIRG-QWRGUYRKSA-N aspartame Chemical compound OC(=O)C[C@H](N)C(=O)N[C@H](C(=O)OC)CC1=CC=CC=C1 IAOZJIPTCAWIRG-QWRGUYRKSA-N 0.000 description 2
- 235000010357 aspartame Nutrition 0.000 description 2
- 229960003438 aspartame Drugs 0.000 description 2
- HUMNYLRZRPPJDN-UHFFFAOYSA-N benzaldehyde Chemical compound O=CC1=CC=CC=C1 HUMNYLRZRPPJDN-UHFFFAOYSA-N 0.000 description 2
- 239000000872 buffer Substances 0.000 description 2
- 229910000019 calcium carbonate Inorganic materials 0.000 description 2
- 229940043256 calcium pyrophosphate Drugs 0.000 description 2
- YKPUWZUDDOIDPM-SOFGYWHQSA-N capsaicin Chemical compound COC1=CC(CNC(=O)CCCC\C=C\C(C)C)=CC=C1O YKPUWZUDDOIDPM-SOFGYWHQSA-N 0.000 description 2
- 235000004654 carnosol Nutrition 0.000 description 2
- 235000010418 carrageenan Nutrition 0.000 description 2
- 239000000679 carrageenan Substances 0.000 description 2
- 229920001525 carrageenan Polymers 0.000 description 2
- 229940113118 carrageenan Drugs 0.000 description 2
- 239000012876 carrier material Substances 0.000 description 2
- YCIMNLLNPGFGHC-UHFFFAOYSA-N catechol Chemical compound OC1=CC=CC=C1O YCIMNLLNPGFGHC-UHFFFAOYSA-N 0.000 description 2
- 239000002738 chelating agent Substances 0.000 description 2
- 239000004927 clay Substances 0.000 description 2
- 238000004140 cleaning Methods 0.000 description 2
- 239000010634 clove oil Substances 0.000 description 2
- 235000005822 corn Nutrition 0.000 description 2
- 208000002925 dental caries Diseases 0.000 description 2
- RBLGLDWTCZMLRW-UHFFFAOYSA-K dicalcium;phosphate;dihydrate Chemical compound O.O.[Ca+2].[Ca+2].[O-]P([O-])([O-])=O RBLGLDWTCZMLRW-UHFFFAOYSA-K 0.000 description 2
- 239000003085 diluting agent Substances 0.000 description 2
- XEYBRNLFEZDVAW-ARSRFYASSA-N dinoprostone Chemical compound CCCCC[C@H](O)\C=C\[C@H]1[C@H](O)CC(=O)[C@@H]1C\C=C/CCCC(O)=O XEYBRNLFEZDVAW-ARSRFYASSA-N 0.000 description 2
- 229960002986 dinoprostone Drugs 0.000 description 2
- XPPKVPWEQAFLFU-UHFFFAOYSA-J diphosphate(4-) Chemical compound [O-]P([O-])(=O)OP([O-])([O-])=O XPPKVPWEQAFLFU-UHFFFAOYSA-J 0.000 description 2
- 239000000975 dye Substances 0.000 description 2
- 239000000806 elastomer Substances 0.000 description 2
- 239000010642 eucalyptus oil Substances 0.000 description 2
- 229940044949 eucalyptus oil Drugs 0.000 description 2
- RRAFCDWBNXTKKO-UHFFFAOYSA-N eugenol Chemical compound COC1=CC(CC=C)=CC=C1O RRAFCDWBNXTKKO-UHFFFAOYSA-N 0.000 description 2
- 150000002222 fluorine compounds Chemical class 0.000 description 2
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 description 2
- 238000009472 formulation Methods 0.000 description 2
- 229960002737 fructose Drugs 0.000 description 2
- UPBDXRPQPOWRKR-UHFFFAOYSA-N furan-2,5-dione;methoxyethene Chemical compound COC=C.O=C1OC(=O)C=C1 UPBDXRPQPOWRKR-UHFFFAOYSA-N 0.000 description 2
- 229960001867 guaiacol Drugs 0.000 description 2
- 230000036541 health Effects 0.000 description 2
- JYGXADMDTFJGBT-VWUMJDOOSA-N hydrocortisone Chemical compound O=C1CC[C@]2(C)[C@H]3[C@@H](O)C[C@](C)([C@@](CC4)(O)C(=O)CO)[C@@H]4[C@@H]3CCC2=C1 JYGXADMDTFJGBT-VWUMJDOOSA-N 0.000 description 2
- 229960000905 indomethacin Drugs 0.000 description 2
- 230000002401 inhibitory effect Effects 0.000 description 2
- CDOSHBSSFJOMGT-UHFFFAOYSA-N linalool Chemical compound CC(C)=CCCC(C)(O)C=C CDOSHBSSFJOMGT-UHFFFAOYSA-N 0.000 description 2
- 239000004337 magnesium citrate Substances 0.000 description 2
- 229960005336 magnesium citrate Drugs 0.000 description 2
- 235000002538 magnesium citrate Nutrition 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 description 2
- 229960001047 methyl salicylate Drugs 0.000 description 2
- XJRBAMWJDBPFIM-UHFFFAOYSA-N methyl vinyl ether Chemical compound COC=C XJRBAMWJDBPFIM-UHFFFAOYSA-N 0.000 description 2
- 239000010445 mica Substances 0.000 description 2
- 229910052618 mica group Inorganic materials 0.000 description 2
- 150000002894 organic compounds Chemical class 0.000 description 2
- 230000001151 other effect Effects 0.000 description 2
- 239000002245 particle Substances 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 2
- 239000010452 phosphate Substances 0.000 description 2
- 239000001205 polyphosphate Substances 0.000 description 2
- 235000011176 polyphosphates Nutrition 0.000 description 2
- QELSKZZBTMNZEB-UHFFFAOYSA-N propylparaben Chemical compound CCCOC(=O)C1=CC=C(O)C=C1 QELSKZZBTMNZEB-UHFFFAOYSA-N 0.000 description 2
- XEYBRNLFEZDVAW-UHFFFAOYSA-N prostaglandin E2 Natural products CCCCCC(O)C=CC1C(O)CC(=O)C1CC=CCCCC(O)=O XEYBRNLFEZDVAW-UHFFFAOYSA-N 0.000 description 2
- 150000003180 prostaglandins Chemical class 0.000 description 2
- 235000002020 sage Nutrition 0.000 description 2
- YGSDEFSMJLZEOE-UHFFFAOYSA-M salicylate Chemical compound OC1=CC=CC=C1C([O-])=O YGSDEFSMJLZEOE-UHFFFAOYSA-M 0.000 description 2
- 229960001860 salicylate Drugs 0.000 description 2
- YKOLYTVUIVUUDY-UHFFFAOYSA-K sodium;zinc;2-hydroxypropane-1,2,3-tricarboxylate Chemical compound [Na+].[Zn+2].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O YKOLYTVUIVUUDY-UHFFFAOYSA-K 0.000 description 2
- 239000000243 solution Substances 0.000 description 2
- 239000004575 stone Substances 0.000 description 2
- BDHFUVZGWQCTTF-UHFFFAOYSA-M sulfonate Chemical compound [O-]S(=O)=O BDHFUVZGWQCTTF-UHFFFAOYSA-M 0.000 description 2
- 239000006188 syrup Substances 0.000 description 2
- 235000020357 syrup Nutrition 0.000 description 2
- 229960000790 thymol Drugs 0.000 description 2
- 239000011135 tin Substances 0.000 description 2
- 229910052718 tin Inorganic materials 0.000 description 2
- YUOWTJMRMWQJDA-UHFFFAOYSA-J tin(iv) fluoride Chemical compound [F-].[F-].[F-].[F-].[Sn+4] YUOWTJMRMWQJDA-UHFFFAOYSA-J 0.000 description 2
- PLSARIKBYIPYPF-UHFFFAOYSA-H trimagnesium dicitrate Chemical compound [Mg+2].[Mg+2].[Mg+2].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O.[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O PLSARIKBYIPYPF-UHFFFAOYSA-H 0.000 description 2
- RYFMWSXOAZQYPI-UHFFFAOYSA-K trisodium phosphate Chemical class [Na+].[Na+].[Na+].[O-]P([O-])([O-])=O RYFMWSXOAZQYPI-UHFFFAOYSA-K 0.000 description 2
- WGIWBXUNRXCYRA-UHFFFAOYSA-H trizinc;2-hydroxypropane-1,2,3-tricarboxylate Chemical compound [Zn+2].[Zn+2].[Zn+2].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O.[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O WGIWBXUNRXCYRA-UHFFFAOYSA-H 0.000 description 2
- 239000004034 viscosity adjusting agent Substances 0.000 description 2
- 235000010447 xylitol Nutrition 0.000 description 2
- 239000000811 xylitol Substances 0.000 description 2
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 description 2
- 229960002675 xylitol Drugs 0.000 description 2
- 239000011701 zinc Substances 0.000 description 2
- 229910052725 zinc Inorganic materials 0.000 description 2
- 239000004246 zinc acetate Substances 0.000 description 2
- 235000013904 zinc acetate Nutrition 0.000 description 2
- 239000011746 zinc citrate Substances 0.000 description 2
- 235000006076 zinc citrate Nutrition 0.000 description 2
- 229940068475 zinc citrate Drugs 0.000 description 2
- 229940071566 zinc glycinate Drugs 0.000 description 2
- 229960001296 zinc oxide Drugs 0.000 description 2
- NWONKYPBYAMBJT-UHFFFAOYSA-L zinc sulfate Chemical compound [Zn+2].[O-]S([O-])(=O)=O NWONKYPBYAMBJT-UHFFFAOYSA-L 0.000 description 2
- 229960001763 zinc sulfate Drugs 0.000 description 2
- 229910000368 zinc sulfate Inorganic materials 0.000 description 2
- UOXSXMSTSYWNMH-UHFFFAOYSA-L zinc;2-aminoacetate Chemical compound [Zn+2].NCC([O-])=O.NCC([O-])=O UOXSXMSTSYWNMH-UHFFFAOYSA-L 0.000 description 2
- NFLGAXVYCFJBMK-RKDXNWHRSA-N (+)-isomenthone Natural products CC(C)[C@H]1CC[C@@H](C)CC1=O NFLGAXVYCFJBMK-RKDXNWHRSA-N 0.000 description 1
- RDJGLLICXDHJDY-NSHDSACASA-N (2s)-2-(3-phenoxyphenyl)propanoic acid Chemical compound OC(=O)[C@@H](C)C1=CC=CC(OC=2C=CC=CC=2)=C1 RDJGLLICXDHJDY-NSHDSACASA-N 0.000 description 1
- 239000001490 (3R)-3,7-dimethylocta-1,6-dien-3-ol Substances 0.000 description 1
- SGKRLCUYIXIAHR-AKNGSSGZSA-N (4s,4ar,5s,5ar,6r,12ar)-4-(dimethylamino)-1,5,10,11,12a-pentahydroxy-6-methyl-3,12-dioxo-4a,5,5a,6-tetrahydro-4h-tetracene-2-carboxamide Chemical compound C1=CC=C2[C@H](C)[C@@H]([C@H](O)[C@@H]3[C@](C(O)=C(C(N)=O)C(=O)[C@H]3N(C)C)(O)C3=O)C3=C(O)C2=C1O SGKRLCUYIXIAHR-AKNGSSGZSA-N 0.000 description 1
- FFTVPQUHLQBXQZ-KVUCHLLUSA-N (4s,4as,5ar,12ar)-4,7-bis(dimethylamino)-1,10,11,12a-tetrahydroxy-3,12-dioxo-4a,5,5a,6-tetrahydro-4h-tetracene-2-carboxamide Chemical compound C1C2=C(N(C)C)C=CC(O)=C2C(O)=C2[C@@H]1C[C@H]1[C@H](N(C)C)C(=O)C(C(N)=O)=C(O)[C@@]1(O)C2=O FFTVPQUHLQBXQZ-KVUCHLLUSA-N 0.000 description 1
- 239000001605 (5-methyl-2-propan-2-ylcyclohexyl) acetate Substances 0.000 description 1
- KJPRLNWUNMBNBZ-QPJJXVBHSA-N (E)-cinnamaldehyde Chemical compound O=C\C=C\C1=CC=CC=C1 KJPRLNWUNMBNBZ-QPJJXVBHSA-N 0.000 description 1
- DSSYKIVIOFKYAU-XCBNKYQSSA-N (R)-camphor Chemical compound C1C[C@@]2(C)C(=O)C[C@@H]1C2(C)C DSSYKIVIOFKYAU-XCBNKYQSSA-N 0.000 description 1
- CDOSHBSSFJOMGT-JTQLQIEISA-N (R)-linalool Natural products CC(C)=CCC[C@@](C)(O)C=C CDOSHBSSFJOMGT-JTQLQIEISA-N 0.000 description 1
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 1
- UFLHIIWVXFIJGU-ARJAWSKDSA-N (Z)-hex-3-en-1-ol Chemical compound CC\C=C/CCO UFLHIIWVXFIJGU-ARJAWSKDSA-N 0.000 description 1
- JTYRXXKXOULVAP-UHFFFAOYSA-N 1,2-dibromo-3-phenoxybenzene Chemical group BrC1=CC=CC(OC=2C=CC=CC=2)=C1Br JTYRXXKXOULVAP-UHFFFAOYSA-N 0.000 description 1
- LDVVTQMJQSCDMK-UHFFFAOYSA-N 1,3-dihydroxypropan-2-yl formate Chemical compound OCC(CO)OC=O LDVVTQMJQSCDMK-UHFFFAOYSA-N 0.000 description 1
- RTBFRGCFXZNCOE-UHFFFAOYSA-N 1-methylsulfonylpiperidin-4-one Chemical compound CS(=O)(=O)N1CCC(=O)CC1 RTBFRGCFXZNCOE-UHFFFAOYSA-N 0.000 description 1
- YFVBASFBIJFBAI-UHFFFAOYSA-M 1-tetradecylpyridin-1-ium;chloride Chemical compound [Cl-].CCCCCCCCCCCCCC[N+]1=CC=CC=C1 YFVBASFBIJFBAI-UHFFFAOYSA-M 0.000 description 1
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 description 1
- SMZOUWXMTYCWNB-UHFFFAOYSA-N 2-(2-methoxy-5-methylphenyl)ethanamine Chemical compound COC1=CC=C(C)C=C1CCN SMZOUWXMTYCWNB-UHFFFAOYSA-N 0.000 description 1
- GEZAUFNYMZVOFV-UHFFFAOYSA-J 2-[(2-oxo-1,3,2$l^{5},4$l^{2}-dioxaphosphastannetan-2-yl)oxy]-1,3,2$l^{5},4$l^{2}-dioxaphosphastannetane 2-oxide Chemical compound [Sn+2].[Sn+2].[O-]P([O-])(=O)OP([O-])([O-])=O GEZAUFNYMZVOFV-UHFFFAOYSA-J 0.000 description 1
- RWMSXNCJNSILON-UHFFFAOYSA-N 2-[4-(2-propylpentyl)piperidin-1-yl]ethanol Chemical compound CCCC(CCC)CC1CCN(CCO)CC1 RWMSXNCJNSILON-UHFFFAOYSA-N 0.000 description 1
- CDMGNVWZXRKJNS-UHFFFAOYSA-N 2-benzylphenol Chemical compound OC1=CC=CC=C1CC1=CC=CC=C1 CDMGNVWZXRKJNS-UHFFFAOYSA-N 0.000 description 1
- KANYJWVOXXLHJE-UHFFFAOYSA-J 3,3'-spirobi[2,4,3-benzodioxastannepine]-1,1',5,5'-tetrone Chemical compound C(C=1C(C(=O)[O-])=CC=CC1)(=O)[O-].[Sn+4].C(C=1C(C(=O)[O-])=CC=CC1)(=O)[O-] KANYJWVOXXLHJE-UHFFFAOYSA-J 0.000 description 1
- DISYHRKLFBBFAS-UHFFFAOYSA-N 3-(1-methyl-4-propan-2-ylcyclohexyl)oxypropane-1,2-diol Chemical compound CC(C)C1CCC(C)(OCC(O)CO)CC1 DISYHRKLFBBFAS-UHFFFAOYSA-N 0.000 description 1
- UBLAMKHIFZBBSS-UHFFFAOYSA-N 3-Methylbutyl pentanoate Chemical compound CCCCC(=O)OCCC(C)C UBLAMKHIFZBBSS-UHFFFAOYSA-N 0.000 description 1
- DUKKNDLIWRYBCT-UHFFFAOYSA-N 3-bromo-2-chlorophenol Chemical compound OC1=CC=CC(Br)=C1Cl DUKKNDLIWRYBCT-UHFFFAOYSA-N 0.000 description 1
- ANAAMBRRWOGKGU-UHFFFAOYSA-M 4-ethyl-1-tetradecylpyridin-1-ium;chloride Chemical compound [Cl-].CCCCCCCCCCCCCC[N+]1=CC=C(CC)C=C1 ANAAMBRRWOGKGU-UHFFFAOYSA-M 0.000 description 1
- MDXYNRAMDATLBT-UHFFFAOYSA-N 4-prop-1-enylbenzene-1,2-diol Chemical compound CC=CC1=CC=C(O)C(O)=C1 MDXYNRAMDATLBT-UHFFFAOYSA-N 0.000 description 1
- OZJPLYNZGCXSJM-UHFFFAOYSA-N 5-valerolactone Chemical compound O=C1CCCCO1 OZJPLYNZGCXSJM-UHFFFAOYSA-N 0.000 description 1
- 244000215068 Acacia senegal Species 0.000 description 1
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 1
- 244000036975 Ambrosia artemisiifolia Species 0.000 description 1
- 235000003129 Ambrosia artemisiifolia var elatior Nutrition 0.000 description 1
- ATRRKUHOCOJYRX-UHFFFAOYSA-N Ammonium bicarbonate Chemical compound [NH4+].OC([O-])=O ATRRKUHOCOJYRX-UHFFFAOYSA-N 0.000 description 1
- 229910000013 Ammonium bicarbonate Inorganic materials 0.000 description 1
- 244000144725 Amygdalus communis Species 0.000 description 1
- 235000007119 Ananas comosus Nutrition 0.000 description 1
- 244000099147 Ananas comosus Species 0.000 description 1
- 240000007087 Apium graveolens Species 0.000 description 1
- 244000105624 Arachis hypogaea Species 0.000 description 1
- BSYNRYMUTXBXSQ-UHFFFAOYSA-N Aspirin Chemical compound CC(=O)OC1=CC=CC=C1C(O)=O BSYNRYMUTXBXSQ-UHFFFAOYSA-N 0.000 description 1
- 241000416162 Astragalus gummifer Species 0.000 description 1
- MDZKJHQSJHYOHJ-KRGADYIYSA-N Augustic acid Natural products C1[C@H](O)[C@H](O)C(C)(C)[C@@H]2CC[C@@]3(C)[C@]4(C)CC[C@@]5(C(O)=O)CCC(C)(C)C[C@H]5C4=CC[C@@H]3[C@]21C MDZKJHQSJHYOHJ-KRGADYIYSA-N 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- MOZDKDIOPSPTBH-UHFFFAOYSA-N Benzyl parahydroxybenzoate Chemical compound C1=CC(O)=CC=C1C(=O)OCC1=CC=CC=C1 MOZDKDIOPSPTBH-UHFFFAOYSA-N 0.000 description 1
- KWIUHFFTVRNATP-UHFFFAOYSA-N Betaine Natural products C[N+](C)(C)CC([O-])=O KWIUHFFTVRNATP-UHFFFAOYSA-N 0.000 description 1
- 229940122361 Bisphosphonate Drugs 0.000 description 1
- LSNNMFCWUKXFEE-UHFFFAOYSA-M Bisulfite Chemical compound OS([O-])=O LSNNMFCWUKXFEE-UHFFFAOYSA-M 0.000 description 1
- 239000004135 Bone phosphate Substances 0.000 description 1
- BTBUEUYNUDRHOZ-UHFFFAOYSA-N Borate Chemical compound [O-]B([O-])[O-] BTBUEUYNUDRHOZ-UHFFFAOYSA-N 0.000 description 1
- 241000167854 Bourreria succulenta Species 0.000 description 1
- 239000004255 Butylated hydroxyanisole Substances 0.000 description 1
- 239000004322 Butylated hydroxytoluene Substances 0.000 description 1
- NLZUEZXRPGMBCV-UHFFFAOYSA-N Butylhydroxytoluene Chemical compound CC1=CC(C(C)(C)C)=C(O)C(C(C)(C)C)=C1 NLZUEZXRPGMBCV-UHFFFAOYSA-N 0.000 description 1
- QFOHBWFCKVYLES-UHFFFAOYSA-N Butylparaben Chemical compound CCCCOC(=O)C1=CC=C(O)C=C1 QFOHBWFCKVYLES-UHFFFAOYSA-N 0.000 description 1
- IQLVOOAAHSZSMN-UHFFFAOYSA-N C1C(CCCCC1)(P(O)(=O)O)P(O)(=O)O.[N] Chemical compound C1C(CCCCC1)(P(O)(=O)O)P(O)(=O)O.[N] IQLVOOAAHSZSMN-UHFFFAOYSA-N 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 239000001736 Calcium glycerylphosphate Substances 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical group [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- BVKZGUZCCUSVTD-UHFFFAOYSA-L Carbonate Chemical compound [O-]C([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-L 0.000 description 1
- 229920002134 Carboxymethyl cellulose Polymers 0.000 description 1
- 235000009467 Carica papaya Nutrition 0.000 description 1
- 240000006432 Carica papaya Species 0.000 description 1
- NPBVQXIMTZKSBA-UHFFFAOYSA-N Chavibetol Natural products COC1=CC=C(CC=C)C=C1O NPBVQXIMTZKSBA-UHFFFAOYSA-N 0.000 description 1
- GHOKWGTUZJEAQD-UHFFFAOYSA-N Chick antidermatitis factor Natural products OCC(C)(C)C(O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-UHFFFAOYSA-N 0.000 description 1
- GHXZTYHSJHQHIJ-UHFFFAOYSA-N Chlorhexidine Chemical compound C=1C=C(Cl)C=CC=1NC(N)=NC(N)=NCCCCCCN=C(N)N=C(N)NC1=CC=C(Cl)C=C1 GHXZTYHSJHQHIJ-UHFFFAOYSA-N 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 1
- 241000206575 Chondrus crispus Species 0.000 description 1
- 241000723346 Cinnamomum camphora Species 0.000 description 1
- WTEVQBCEXWBHNA-UHFFFAOYSA-N Citral Natural products CC(C)=CCCC(C)=CC=O WTEVQBCEXWBHNA-UHFFFAOYSA-N 0.000 description 1
- 235000008733 Citrus aurantifolia Nutrition 0.000 description 1
- 235000019499 Citrus oil Nutrition 0.000 description 1
- 240000000560 Citrus x paradisi Species 0.000 description 1
- HZZVJAQRINQKSD-UHFFFAOYSA-N Clavulanic acid Natural products OC(=O)C1C(=CCO)OC2CC(=O)N21 HZZVJAQRINQKSD-UHFFFAOYSA-N 0.000 description 1
- 240000007154 Coffea arabica Species 0.000 description 1
- 235000016795 Cola Nutrition 0.000 description 1
- 241001634499 Cola Species 0.000 description 1
- 235000011824 Cola pachycarpa Nutrition 0.000 description 1
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 1
- JPVYNHNXODAKFH-UHFFFAOYSA-N Cu2+ Chemical class [Cu+2] JPVYNHNXODAKFH-UHFFFAOYSA-N 0.000 description 1
- XFXPMWWXUTWYJX-UHFFFAOYSA-N Cyanide Chemical compound N#[C-] XFXPMWWXUTWYJX-UHFFFAOYSA-N 0.000 description 1
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 1
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 1
- RGHNJXZEOKUKBD-SQOUGZDYSA-M D-gluconate Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O RGHNJXZEOKUKBD-SQOUGZDYSA-M 0.000 description 1
- WQZGKKKJIJFFOK-QTVWNMPRSA-N D-mannopyranose Chemical compound OC[C@H]1OC(O)[C@@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-QTVWNMPRSA-N 0.000 description 1
- XHXUANMFYXWVNG-UHFFFAOYSA-N D-menthyl acetate Natural products CC(C)C1CCC(C)CC1OC(C)=O XHXUANMFYXWVNG-UHFFFAOYSA-N 0.000 description 1
- HMFHBZSHGGEWLO-SOOFDHNKSA-N D-ribofuranose Chemical compound OC[C@H]1OC(O)[C@H](O)[C@@H]1O HMFHBZSHGGEWLO-SOOFDHNKSA-N 0.000 description 1
- 208000002064 Dental Plaque Diseases 0.000 description 1
- 239000004375 Dextrin Substances 0.000 description 1
- 229920001353 Dextrin Polymers 0.000 description 1
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 1
- VGGSQFUCUMXWEO-UHFFFAOYSA-N Ethene Chemical compound C=C VGGSQFUCUMXWEO-UHFFFAOYSA-N 0.000 description 1
- 239000005977 Ethylene Substances 0.000 description 1
- 244000004281 Eucalyptus maculata Species 0.000 description 1
- 239000005770 Eugenol Substances 0.000 description 1
- 241000628997 Flos Species 0.000 description 1
- 235000016623 Fragaria vesca Nutrition 0.000 description 1
- 240000009088 Fragaria x ananassa Species 0.000 description 1
- 235000011363 Fragaria x ananassa Nutrition 0.000 description 1
- 229930091371 Fructose Natural products 0.000 description 1
- 239000005715 Fructose Substances 0.000 description 1
- 108010073178 Glucan 1,4-alpha-Glucosidase Proteins 0.000 description 1
- 102100022624 Glucoamylase Human genes 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 108010015776 Glucose oxidase Proteins 0.000 description 1
- 239000004366 Glucose oxidase Substances 0.000 description 1
- 229920000084 Gum arabic Polymers 0.000 description 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 1
- 229920001908 Hydrogenated starch hydrolysate Polymers 0.000 description 1
- 239000004354 Hydroxyethyl cellulose Substances 0.000 description 1
- 229920000663 Hydroxyethyl cellulose Polymers 0.000 description 1
- HEFNNWSXXWATRW-UHFFFAOYSA-N Ibuprofen Chemical compound CC(C)CC1=CC=C(C(C)C(O)=O)C=C1 HEFNNWSXXWATRW-UHFFFAOYSA-N 0.000 description 1
- AYRXSINWFIIFAE-SCLMCMATSA-N Isomaltose Natural products OC[C@H]1O[C@H](OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C=O)[C@@H](O)[C@@H](O)[C@@H]1O AYRXSINWFIIFAE-SCLMCMATSA-N 0.000 description 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 description 1
- 241000220225 Malus Species 0.000 description 1
- 235000011430 Malus pumila Nutrition 0.000 description 1
- 235000015103 Malus silvestris Nutrition 0.000 description 1
- 229930195725 Mannitol Natural products 0.000 description 1
- 235000014749 Mentha crispa Nutrition 0.000 description 1
- 244000078639 Mentha spicata Species 0.000 description 1
- CERQOIWHTDAKMF-UHFFFAOYSA-N Methacrylic acid Chemical compound CC(=C)C(O)=O CERQOIWHTDAKMF-UHFFFAOYSA-N 0.000 description 1
- 240000005561 Musa balbisiana Species 0.000 description 1
- 235000018290 Musa x paradisiaca Nutrition 0.000 description 1
- OVBPIULPVIDEAO-UHFFFAOYSA-N N-Pteroyl-L-glutaminsaeure Natural products C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-UHFFFAOYSA-N 0.000 description 1
- BLXXJMDCKKHMKV-UHFFFAOYSA-N Nabumetone Chemical compound C1=C(CCC(C)=O)C=CC2=CC(OC)=CC=C21 BLXXJMDCKKHMKV-UHFFFAOYSA-N 0.000 description 1
- CMWTZPSULFXXJA-UHFFFAOYSA-N Naproxen Natural products C1=C(C(C)C(O)=O)C=CC2=CC(OC)=CC=C21 CMWTZPSULFXXJA-UHFFFAOYSA-N 0.000 description 1
- 229930193140 Neomycin Natural products 0.000 description 1
- 239000004384 Neotame Substances 0.000 description 1
- DMXHXBGUNHLMQO-IWLDQSELSA-N Nepitrin Chemical compound C1=C2OC(C=3C=C(O)C(O)=CC=3)=CC(=O)C2=C(O)C(OC)=C1O[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O DMXHXBGUNHLMQO-IWLDQSELSA-N 0.000 description 1
- SGOMZDKEAPBAGC-UHFFFAOYSA-N Nepitrin Natural products COC1C(O)C(O)C(Oc2cc3OC(=CC(=O)c3c(O)c2OC)c4ccc(O)c(O)c4)OC1CO SGOMZDKEAPBAGC-UHFFFAOYSA-N 0.000 description 1
- CQVPPLWYIDMWDA-UHFFFAOYSA-N OS(=O)(=O)c1ccccc1.CCCCCCCCCCCC[Na] Chemical compound OS(=O)(=O)c1ccccc1.CCCCCCCCCCCC[Na] CQVPPLWYIDMWDA-UHFFFAOYSA-N 0.000 description 1
- 208000025157 Oral disease Diseases 0.000 description 1
- 102000035195 Peptidases Human genes 0.000 description 1
- 108091005804 Peptidases Proteins 0.000 description 1
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 1
- 239000002202 Polyethylene glycol Substances 0.000 description 1
- 108010020346 Polyglutamic Acid Proteins 0.000 description 1
- 229920002367 Polyisobutene Polymers 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical group [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- 240000000103 Potentilla erecta Species 0.000 description 1
- 235000016551 Potentilla erecta Nutrition 0.000 description 1
- 239000004365 Protease Substances 0.000 description 1
- 108010009736 Protein Hydrolysates Proteins 0.000 description 1
- 235000009827 Prunus armeniaca Nutrition 0.000 description 1
- 244000018633 Prunus armeniaca Species 0.000 description 1
- UVMRYBDEERADNV-UHFFFAOYSA-N Pseudoeugenol Natural products COC1=CC(C(C)=C)=CC=C1O UVMRYBDEERADNV-UHFFFAOYSA-N 0.000 description 1
- 239000004373 Pullulan Substances 0.000 description 1
- 229920001218 Pullulan Polymers 0.000 description 1
- 241000282806 Rhinoceros Species 0.000 description 1
- PYMYPHUHKUWMLA-LMVFSUKVSA-N Ribose Natural products OC[C@@H](O)[C@@H](O)[C@@H](O)C=O PYMYPHUHKUWMLA-LMVFSUKVSA-N 0.000 description 1
- 108010077895 Sarcosine Proteins 0.000 description 1
- UIIMBOGNXHQVGW-DEQYMQKBSA-M Sodium bicarbonate-14C Chemical compound [Na+].O[14C]([O-])=O UIIMBOGNXHQVGW-DEQYMQKBSA-M 0.000 description 1
- DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 235000015125 Sterculia urens Nutrition 0.000 description 1
- 240000001058 Sterculia urens Species 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 1
- 240000004584 Tamarindus indica Species 0.000 description 1
- 235000004298 Tamarindus indica Nutrition 0.000 description 1
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 1
- 239000004098 Tetracycline Substances 0.000 description 1
- 244000299461 Theobroma cacao Species 0.000 description 1
- 235000009470 Theobroma cacao Nutrition 0.000 description 1
- 235000011941 Tilia x europaea Nutrition 0.000 description 1
- 240000006909 Tilia x europaea Species 0.000 description 1
- ATJFFYVFTNAWJD-UHFFFAOYSA-N Tin Chemical compound [Sn] ATJFFYVFTNAWJD-UHFFFAOYSA-N 0.000 description 1
- RTAQQCXQSZGOHL-UHFFFAOYSA-N Titanium Chemical compound [Ti] RTAQQCXQSZGOHL-UHFFFAOYSA-N 0.000 description 1
- 229920001615 Tragacanth Polymers 0.000 description 1
- DJSISFGPUUYILV-UHFFFAOYSA-N UNPD161792 Natural products O1C(C(O)=O)C(O)C(O)C(O)C1OC(C(=C1O)O)=CC2=C1C(=O)C=C(C=1C=CC(O)=CC=1)O2 DJSISFGPUUYILV-UHFFFAOYSA-N 0.000 description 1
- 229920001807 Urea-formaldehyde Polymers 0.000 description 1
- 235000009499 Vanilla fragrans Nutrition 0.000 description 1
- 244000263375 Vanilla tahitensis Species 0.000 description 1
- 235000012036 Vanilla tahitensis Nutrition 0.000 description 1
- QYKIQEUNHZKYBP-UHFFFAOYSA-N Vinyl ether Chemical compound C=COC=C QYKIQEUNHZKYBP-UHFFFAOYSA-N 0.000 description 1
- 229930003571 Vitamin B5 Natural products 0.000 description 1
- 229930003268 Vitamin C Natural products 0.000 description 1
- 229930003427 Vitamin E Natural products 0.000 description 1
- 235000009754 Vitis X bourquina Nutrition 0.000 description 1
- 235000012333 Vitis X labruscana Nutrition 0.000 description 1
- 240000006365 Vitis vinifera Species 0.000 description 1
- 235000014787 Vitis vinifera Nutrition 0.000 description 1
- UJNOLBSYLSYIBM-WISYIIOYSA-N [(1r,2s,5r)-5-methyl-2-propan-2-ylcyclohexyl] (2r)-2-hydroxypropanoate Chemical compound CC(C)[C@@H]1CC[C@@H](C)C[C@H]1OC(=O)[C@@H](C)O UJNOLBSYLSYIBM-WISYIIOYSA-N 0.000 description 1
- 235000010489 acacia gum Nutrition 0.000 description 1
- 239000000205 acacia gum Substances 0.000 description 1
- DPXJVFZANSGRMM-UHFFFAOYSA-N acetic acid;2,3,4,5,6-pentahydroxyhexanal;sodium Chemical compound [Na].CC(O)=O.OCC(O)C(O)C(O)C(O)C=O DPXJVFZANSGRMM-UHFFFAOYSA-N 0.000 description 1
- WTHXTWHYLIZJBH-UHFFFAOYSA-N acetic acid;azane Chemical compound N.CC(O)=O.CC(O)=O.CC(O)=O.CC(O)=O WTHXTWHYLIZJBH-UHFFFAOYSA-N 0.000 description 1
- 229960001138 acetylsalicylic acid Drugs 0.000 description 1
- 150000008043 acidic salts Chemical class 0.000 description 1
- 239000002535 acidifier Substances 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 210000000593 adipose tissue white Anatomy 0.000 description 1
- 238000013019 agitation Methods 0.000 description 1
- 229950010221 alexidine Drugs 0.000 description 1
- LFVVNPBBFUSSHL-UHFFFAOYSA-N alexidine Chemical compound CCCCC(CC)CNC(=N)NC(=N)NCCCCCCNC(=N)NC(=N)NCC(CC)CCCC LFVVNPBBFUSSHL-UHFFFAOYSA-N 0.000 description 1
- 125000001931 aliphatic group Chemical group 0.000 description 1
- 150000008044 alkali metal hydroxides Chemical class 0.000 description 1
- 150000001340 alkali metals Chemical class 0.000 description 1
- 150000008051 alkyl sulfates Chemical class 0.000 description 1
- 235000020224 almond Nutrition 0.000 description 1
- HMFHBZSHGGEWLO-UHFFFAOYSA-N alpha-D-Furanose-Ribose Natural products OCC1OC(O)C(O)C1O HMFHBZSHGGEWLO-UHFFFAOYSA-N 0.000 description 1
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 1
- UZFLPKAIBPNNCA-BQYQJAHWSA-N alpha-ionone Chemical compound CC(=O)\C=C\C1C(C)=CCCC1(C)C UZFLPKAIBPNNCA-BQYQJAHWSA-N 0.000 description 1
- UZFLPKAIBPNNCA-UHFFFAOYSA-N alpha-ionone Natural products CC(=O)C=CC1C(C)=CCCC1(C)C UZFLPKAIBPNNCA-UHFFFAOYSA-N 0.000 description 1
- PNEYBMLMFCGWSK-UHFFFAOYSA-N aluminium oxide Inorganic materials [O-2].[O-2].[O-2].[Al+3].[Al+3] PNEYBMLMFCGWSK-UHFFFAOYSA-N 0.000 description 1
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 1
- SNAAJJQQZSMGQD-UHFFFAOYSA-N aluminum magnesium Chemical compound [Mg].[Al] SNAAJJQQZSMGQD-UHFFFAOYSA-N 0.000 description 1
- 235000012538 ammonium bicarbonate Nutrition 0.000 description 1
- 239000001099 ammonium carbonate Substances 0.000 description 1
- 150000003863 ammonium salts Chemical class 0.000 description 1
- LSQZJLSUYDQPKJ-NJBDSQKTSA-N amoxicillin Chemical compound C1([C@@H](N)C(=O)N[C@H]2[C@H]3SC([C@@H](N3C2=O)C(O)=O)(C)C)=CC=C(O)C=C1 LSQZJLSUYDQPKJ-NJBDSQKTSA-N 0.000 description 1
- 229960003022 amoxicillin Drugs 0.000 description 1
- 239000002280 amphoteric surfactant Substances 0.000 description 1
- JFCQEDHGNNZCLN-UHFFFAOYSA-N anhydrous glutaric acid Natural products OC(=O)CCCC(O)=O JFCQEDHGNNZCLN-UHFFFAOYSA-N 0.000 description 1
- 239000003945 anionic surfactant Substances 0.000 description 1
- 239000010617 anise oil Substances 0.000 description 1
- 235000003484 annual ragweed Nutrition 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- KZNIFHPLKGYRTM-UHFFFAOYSA-N apigenin Chemical compound C1=CC(O)=CC=C1C1=CC(=O)C2=C(O)C=C(O)C=C2O1 KZNIFHPLKGYRTM-UHFFFAOYSA-N 0.000 description 1
- XADJWCRESPGUTB-UHFFFAOYSA-N apigenin Natural products C1=CC(O)=CC=C1C1=CC(=O)C2=CC(O)=C(O)C=C2O1 XADJWCRESPGUTB-UHFFFAOYSA-N 0.000 description 1
- 235000008714 apigenin Nutrition 0.000 description 1
- 229940117893 apigenin Drugs 0.000 description 1
- PYMYPHUHKUWMLA-UHFFFAOYSA-N arabinose Natural products OCC(O)C(O)C(O)C=O PYMYPHUHKUWMLA-UHFFFAOYSA-N 0.000 description 1
- 239000008122 artificial sweetener Substances 0.000 description 1
- 235000021311 artificial sweeteners Nutrition 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- 229940098164 augmentin Drugs 0.000 description 1
- UHHXUPJJDHEMGX-UHFFFAOYSA-K azanium;manganese(3+);phosphonato phosphate Chemical compound [NH4+].[Mn+3].[O-]P([O-])(=O)OP([O-])([O-])=O UHHXUPJJDHEMGX-UHFFFAOYSA-K 0.000 description 1
- IRERQBUNZFJFGC-UHFFFAOYSA-L azure blue Chemical compound [Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Al+3].[Al+3].[Al+3].[Al+3].[Al+3].[Al+3].[S-]S[S-].[O-][Si]([O-])([O-])[O-].[O-][Si]([O-])([O-])[O-].[O-][Si]([O-])([O-])[O-].[O-][Si]([O-])([O-])[O-].[O-][Si]([O-])([O-])[O-].[O-][Si]([O-])([O-])[O-] IRERQBUNZFJFGC-UHFFFAOYSA-L 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- 159000000009 barium salts Chemical class 0.000 description 1
- OGBUMNBNEWYMNJ-UHFFFAOYSA-N batilol Chemical class CCCCCCCCCCCCCCCCCCOCC(O)CO OGBUMNBNEWYMNJ-UHFFFAOYSA-N 0.000 description 1
- 239000010620 bay oil Substances 0.000 description 1
- 229960000686 benzalkonium chloride Drugs 0.000 description 1
- CADWTSSKOVRVJC-UHFFFAOYSA-N benzyl(dimethyl)azanium;chloride Chemical compound [Cl-].C[NH+](C)CC1=CC=CC=C1 CADWTSSKOVRVJC-UHFFFAOYSA-N 0.000 description 1
- SRBFZHDQGSBBOR-UHFFFAOYSA-N beta-D-Pyranose-Lyxose Natural products OC1COC(O)C(O)C1O SRBFZHDQGSBBOR-UHFFFAOYSA-N 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- GUBGYTABKSRVRQ-QUYVBRFLSA-N beta-maltose Chemical compound OC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@@H]1O GUBGYTABKSRVRQ-QUYVBRFLSA-N 0.000 description 1
- 229960003237 betaine Drugs 0.000 description 1
- 229940073609 bismuth oxychloride Drugs 0.000 description 1
- 150000004663 bisphosphonates Chemical class 0.000 description 1
- 230000001680 brushing effect Effects 0.000 description 1
- 210000005178 buccal mucosa Anatomy 0.000 description 1
- 235000006263 bur ragweed Nutrition 0.000 description 1
- 235000019282 butylated hydroxyanisole Nutrition 0.000 description 1
- CZBZUDVBLSSABA-UHFFFAOYSA-N butylated hydroxyanisole Chemical compound COC1=CC=C(O)C(C(C)(C)C)=C1.COC1=CC=C(O)C=C1C(C)(C)C CZBZUDVBLSSABA-UHFFFAOYSA-N 0.000 description 1
- 229940043253 butylated hydroxyanisole Drugs 0.000 description 1
- 235000010354 butylated hydroxytoluene Nutrition 0.000 description 1
- 229940095259 butylated hydroxytoluene Drugs 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229960005069 calcium Drugs 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 235000001465 calcium Nutrition 0.000 description 1
- FAPWYRCQGJNNSJ-UBKPKTQASA-L calcium D-pantothenic acid Chemical compound [Ca+2].OCC(C)(C)[C@@H](O)C(=O)NCCC([O-])=O.OCC(C)(C)[C@@H](O)C(=O)NCCC([O-])=O FAPWYRCQGJNNSJ-UBKPKTQASA-L 0.000 description 1
- JUNWLZAGQLJVLR-UHFFFAOYSA-J calcium diphosphate Chemical compound [Ca+2].[Ca+2].[O-]P([O-])(=O)OP([O-])([O-])=O JUNWLZAGQLJVLR-UHFFFAOYSA-J 0.000 description 1
- UHHRFSOMMCWGSO-UHFFFAOYSA-L calcium glycerophosphate Chemical compound [Ca+2].OCC(CO)OP([O-])([O-])=O UHHRFSOMMCWGSO-UHFFFAOYSA-L 0.000 description 1
- 229940095618 calcium glycerophosphate Drugs 0.000 description 1
- 235000019299 calcium glycerylphosphate Nutrition 0.000 description 1
- MKJXYGKVIBWPFZ-UHFFFAOYSA-L calcium lactate Chemical compound [Ca+2].CC(O)C([O-])=O.CC(O)C([O-])=O MKJXYGKVIBWPFZ-UHFFFAOYSA-L 0.000 description 1
- 239000001527 calcium lactate Substances 0.000 description 1
- 235000011086 calcium lactate Nutrition 0.000 description 1
- 229960002401 calcium lactate Drugs 0.000 description 1
- 229960002079 calcium pantothenate Drugs 0.000 description 1
- 239000001506 calcium phosphate Substances 0.000 description 1
- 229960000846 camphor Drugs 0.000 description 1
- 229930008380 camphor Natural products 0.000 description 1
- 235000017663 capsaicin Nutrition 0.000 description 1
- 229960002504 capsaicin Drugs 0.000 description 1
- 239000004202 carbamide Substances 0.000 description 1
- 235000013877 carbamide Nutrition 0.000 description 1
- 229960001631 carbomer Drugs 0.000 description 1
- 239000001569 carbon dioxide Substances 0.000 description 1
- 229910002092 carbon dioxide Inorganic materials 0.000 description 1
- BVKZGUZCCUSVTD-UHFFFAOYSA-N carbonic acid Chemical class OC(O)=O BVKZGUZCCUSVTD-UHFFFAOYSA-N 0.000 description 1
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 1
- 150000001735 carboxylic acids Chemical class 0.000 description 1
- 239000000969 carrier Substances 0.000 description 1
- NPLTVGMLNDMOQE-UHFFFAOYSA-N carthamidin Natural products C1=CC(O)=CC=C1C1OC2=CC(O)=C(O)C(O)=C2C(=O)C1 NPLTVGMLNDMOQE-UHFFFAOYSA-N 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 239000007795 chemical reaction product Substances 0.000 description 1
- 235000019693 cherries Nutrition 0.000 description 1
- 229960003260 chlorhexidine Drugs 0.000 description 1
- KJPRLNWUNMBNBZ-UHFFFAOYSA-N cinnamic aldehyde Natural products O=CC=CC1=CC=CC=C1 KJPRLNWUNMBNBZ-UHFFFAOYSA-N 0.000 description 1
- 229940117916 cinnamic aldehyde Drugs 0.000 description 1
- 239000010630 cinnamon oil Substances 0.000 description 1
- IMEYGBIXGJLUIS-UHFFFAOYSA-N cirsiliol Chemical compound C=1C(=O)C=2C(O)=C(OC)C(OC)=CC=2OC=1C1=CC=C(O)C(O)=C1 IMEYGBIXGJLUIS-UHFFFAOYSA-N 0.000 description 1
- 229940043350 citral Drugs 0.000 description 1
- 239000010500 citrus oil Substances 0.000 description 1
- 238000003776 cleavage reaction Methods 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 235000016213 coffee Nutrition 0.000 description 1
- 235000013353 coffee beverage Nutrition 0.000 description 1
- 235000003488 common ragweed Nutrition 0.000 description 1
- 239000007859 condensation product Substances 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 229910052802 copper Inorganic materials 0.000 description 1
- 239000010949 copper Substances 0.000 description 1
- ORTQZVOHEJQUHG-UHFFFAOYSA-L copper(II) chloride Chemical class Cl[Cu]Cl ORTQZVOHEJQUHG-UHFFFAOYSA-L 0.000 description 1
- QSFOWAYMMZCQNF-UHFFFAOYSA-N delmopinol Chemical compound CCCC(CCC)CCCC1COCCN1CCO QSFOWAYMMZCQNF-UHFFFAOYSA-N 0.000 description 1
- 229960003854 delmopinol Drugs 0.000 description 1
- 210000003298 dental enamel Anatomy 0.000 description 1
- 239000004053 dental implant Substances 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 239000003599 detergent Substances 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 235000019425 dextrin Nutrition 0.000 description 1
- 239000008121 dextrose Substances 0.000 description 1
- 235000019821 dicalcium diphosphate Nutrition 0.000 description 1
- 229960001259 diclofenac Drugs 0.000 description 1
- DCOPUUMXTXDBNB-UHFFFAOYSA-N diclofenac Chemical compound OC(=O)CC1=CC=CC=C1NC1=C(Cl)C=CC=C1Cl DCOPUUMXTXDBNB-UHFFFAOYSA-N 0.000 description 1
- HUPFGZXOMWLGNK-UHFFFAOYSA-N diflunisal Chemical compound C1=C(O)C(C(=O)O)=CC(C=2C(=CC(F)=CC=2)F)=C1 HUPFGZXOMWLGNK-UHFFFAOYSA-N 0.000 description 1
- 229960000616 diflunisal Drugs 0.000 description 1
- 125000000118 dimethyl group Chemical group [H]C([H])([H])* 0.000 description 1
- 235000019262 disodium citrate Nutrition 0.000 description 1
- 239000002526 disodium citrate Substances 0.000 description 1
- 235000019820 disodium diphosphate Nutrition 0.000 description 1
- GYQBBRRVRKFJRG-UHFFFAOYSA-L disodium pyrophosphate Chemical compound [Na+].[Na+].OP([O-])(=O)OP(O)([O-])=O GYQBBRRVRKFJRG-UHFFFAOYSA-L 0.000 description 1
- CEYULKASIQJZGP-UHFFFAOYSA-L disodium;2-(carboxymethyl)-2-hydroxybutanedioate Chemical compound [Na+].[Na+].[O-]C(=O)CC(O)(C(=O)O)CC([O-])=O CEYULKASIQJZGP-UHFFFAOYSA-L 0.000 description 1
- 239000006185 dispersion Substances 0.000 description 1
- 229960001859 domiphen bromide Drugs 0.000 description 1
- 229960003722 doxycycline Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 108010017796 epoxidase Proteins 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 239000000469 ethanolic extract Substances 0.000 description 1
- 239000004403 ethyl p-hydroxybenzoate Substances 0.000 description 1
- 235000010228 ethyl p-hydroxybenzoate Nutrition 0.000 description 1
- 229940043351 ethyl-p-hydroxybenzoate Drugs 0.000 description 1
- NUVBSKCKDOMJSU-UHFFFAOYSA-N ethylparaben Chemical compound CCOC(=O)C1=CC=C(O)C=C1 NUVBSKCKDOMJSU-UHFFFAOYSA-N 0.000 description 1
- 229960005293 etodolac Drugs 0.000 description 1
- XFBVBWWRPKNWHW-UHFFFAOYSA-N etodolac Chemical compound C1COC(CC)(CC(O)=O)C2=N[C]3C(CC)=CC=CC3=C21 XFBVBWWRPKNWHW-UHFFFAOYSA-N 0.000 description 1
- 229960002217 eugenol Drugs 0.000 description 1
- 150000002191 fatty alcohols Chemical class 0.000 description 1
- 229960001419 fenoprofen Drugs 0.000 description 1
- 239000000945 filler Substances 0.000 description 1
- 229930003935 flavonoid Natural products 0.000 description 1
- 150000002215 flavonoids Chemical class 0.000 description 1
- 235000017173 flavonoids Nutrition 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 229960002390 flurbiprofen Drugs 0.000 description 1
- SYTBZMRGLBWNTM-UHFFFAOYSA-N flurbiprofen Chemical compound FC1=CC(C(C(O)=O)C)=CC=C1C1=CC=CC=C1 SYTBZMRGLBWNTM-UHFFFAOYSA-N 0.000 description 1
- 238000005187 foaming Methods 0.000 description 1
- 229960000304 folic acid Drugs 0.000 description 1
- 235000019152 folic acid Nutrition 0.000 description 1
- 239000011724 folic acid Substances 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 235000021433 fructose syrup Nutrition 0.000 description 1
- 239000001530 fumaric acid Substances 0.000 description 1
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 1
- WTEVQBCEXWBHNA-JXMROGBWSA-N geranial Chemical compound CC(C)=CCC\C(C)=C\C=O WTEVQBCEXWBHNA-JXMROGBWSA-N 0.000 description 1
- GJMUCSXZXBCQRZ-UHFFFAOYSA-N geraniin Natural products Oc1cc(cc(O)c1O)C(=O)OC2OC3COC(=O)c4cc(O)c(O)c(O)c4c5cc(C(=O)C67OC3C(O6)C2OC(=O)c8cc(O)c(O)c9OC%10(O)C(C(=CC(=O)C%10(O)O)C7=O)c89)c(O)c(O)c5O GJMUCSXZXBCQRZ-UHFFFAOYSA-N 0.000 description 1
- 229930194078 geranin Natural products 0.000 description 1
- 229940050410 gluconate Drugs 0.000 description 1
- 235000019420 glucose oxidase Nutrition 0.000 description 1
- 229940116332 glucose oxidase Drugs 0.000 description 1
- 229940087603 grape seed extract Drugs 0.000 description 1
- 235000002532 grape seed extract Nutrition 0.000 description 1
- 210000001983 hard palate Anatomy 0.000 description 1
- SLKWROUNLHVIIQ-UHFFFAOYSA-N hexachlorocyclohexa-2,5-dien-1-one Chemical compound ClC1=C(Cl)C(Cl)(Cl)C(Cl)=C(Cl)C1=O SLKWROUNLHVIIQ-UHFFFAOYSA-N 0.000 description 1
- 229960000890 hydrocortisone Drugs 0.000 description 1
- 239000001257 hydrogen Substances 0.000 description 1
- 229910052739 hydrogen Inorganic materials 0.000 description 1
- 150000004679 hydroxides Chemical class 0.000 description 1
- 235000019447 hydroxyethyl cellulose Nutrition 0.000 description 1
- 229960001680 ibuprofen Drugs 0.000 description 1
- 238000003018 immunoassay Methods 0.000 description 1
- 239000007943 implant Substances 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 230000006698 induction Effects 0.000 description 1
- 230000004968 inflammatory condition Effects 0.000 description 1
- 239000003112 inhibitor Substances 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 229910010272 inorganic material Inorganic materials 0.000 description 1
- 239000011147 inorganic material Substances 0.000 description 1
- 229910052816 inorganic phosphate Inorganic materials 0.000 description 1
- UQSXHKLRYXJYBZ-UHFFFAOYSA-N iron oxide Inorganic materials [Fe]=O UQSXHKLRYXJYBZ-UHFFFAOYSA-N 0.000 description 1
- DLRVVLDZNNYCBX-RTPHMHGBSA-N isomaltose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1OC[C@@H]1[C@@H](O)[C@H](O)[C@@H](O)C(O)O1 DLRVVLDZNNYCBX-RTPHMHGBSA-N 0.000 description 1
- MWDZOUNAPSSOEL-UHFFFAOYSA-N kaempferol Natural products OC1=C(C(=O)c2cc(O)cc(O)c2O1)c3ccc(O)cc3 MWDZOUNAPSSOEL-UHFFFAOYSA-N 0.000 description 1
- 229960000318 kanamycin Drugs 0.000 description 1
- SBUJHOSQTJFQJX-NOAMYHISSA-N kanamycin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CN)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](N)[C@H](O)[C@@H](CO)O2)O)[C@H](N)C[C@@H]1N SBUJHOSQTJFQJX-NOAMYHISSA-N 0.000 description 1
- 229930027917 kanamycin Natural products 0.000 description 1
- 229930182823 kanamycin A Natural products 0.000 description 1
- DKYWVDODHFEZIM-UHFFFAOYSA-N ketoprofen Chemical compound OC(=O)C(C)C1=CC=CC(C(=O)C=2C=CC=CC=2)=C1 DKYWVDODHFEZIM-UHFFFAOYSA-N 0.000 description 1
- 229960000991 ketoprofen Drugs 0.000 description 1
- 229960004752 ketorolac Drugs 0.000 description 1
- OZWKMVRBQXNZKK-UHFFFAOYSA-N ketorolac Chemical compound OC(=O)C1CCN2C1=CC=C2C(=O)C1=CC=CC=C1 OZWKMVRBQXNZKK-UHFFFAOYSA-N 0.000 description 1
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical class CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 1
- 239000008101 lactose Substances 0.000 description 1
- 229920005610 lignin Polymers 0.000 description 1
- 239000004571 lime Substances 0.000 description 1
- 229930007744 linalool Natural products 0.000 description 1
- 239000006193 liquid solution Substances 0.000 description 1
- 239000006210 lotion Substances 0.000 description 1
- IQPNAANSBPBGFQ-UHFFFAOYSA-N luteolin Chemical compound C=1C(O)=CC(O)=C(C(C=2)=O)C=1OC=2C1=CC=C(O)C(O)=C1 IQPNAANSBPBGFQ-UHFFFAOYSA-N 0.000 description 1
- LRDGATPGVJTWLJ-UHFFFAOYSA-N luteolin Natural products OC1=CC(O)=CC(C=2OC3=CC(O)=CC(O)=C3C(=O)C=2)=C1 LRDGATPGVJTWLJ-UHFFFAOYSA-N 0.000 description 1
- 235000009498 luteolin Nutrition 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- ZLNQQNXFFQJAID-UHFFFAOYSA-L magnesium carbonate Chemical compound [Mg+2].[O-]C([O-])=O ZLNQQNXFFQJAID-UHFFFAOYSA-L 0.000 description 1
- 239000001095 magnesium carbonate Substances 0.000 description 1
- 229910000021 magnesium carbonate Inorganic materials 0.000 description 1
- 229940091250 magnesium supplement Drugs 0.000 description 1
- 239000001630 malic acid Substances 0.000 description 1
- 235000011090 malic acid Nutrition 0.000 description 1
- 239000000845 maltitol Substances 0.000 description 1
- 235000010449 maltitol Nutrition 0.000 description 1
- VQHSOMBJVWLPSR-WUJBLJFYSA-N maltitol Chemical compound OC[C@H](O)[C@@H](O)[C@@H]([C@H](O)CO)O[C@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O VQHSOMBJVWLPSR-WUJBLJFYSA-N 0.000 description 1
- 229940035436 maltitol Drugs 0.000 description 1
- 239000000594 mannitol Substances 0.000 description 1
- 235000010355 mannitol Nutrition 0.000 description 1
- 229960001855 mannitol Drugs 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 229960003464 mefenamic acid Drugs 0.000 description 1
- HYYBABOKPJLUIN-UHFFFAOYSA-N mefenamic acid Chemical compound CC1=CC=CC(NC=2C(=CC=CC=2)C(O)=O)=C1C HYYBABOKPJLUIN-UHFFFAOYSA-N 0.000 description 1
- 239000001525 mentha piperita l. herb oil Substances 0.000 description 1
- 229930007503 menthone Natural products 0.000 description 1
- SJOXEWUZWQYCGL-DVOMOZLQSA-N menthyl salicylate Chemical compound CC(C)[C@@H]1CC[C@@H](C)C[C@H]1OC(=O)C1=CC=CC=C1O SJOXEWUZWQYCGL-DVOMOZLQSA-N 0.000 description 1
- 229960004665 menthyl salicylate Drugs 0.000 description 1
- UZKWTJUDCOPSNM-UHFFFAOYSA-N methoxybenzene Substances CCCCOC=C UZKWTJUDCOPSNM-UHFFFAOYSA-N 0.000 description 1
- BHQQXAOBIZQEGI-UHFFFAOYSA-N methyl 2-chlorobutanoate Chemical compound CCC(Cl)C(=O)OC BHQQXAOBIZQEGI-UHFFFAOYSA-N 0.000 description 1
- 150000004702 methyl esters Chemical class 0.000 description 1
- LXCFILQKKLGQFO-UHFFFAOYSA-N methylparaben Chemical compound COC(=O)C1=CC=C(O)C=C1 LXCFILQKKLGQFO-UHFFFAOYSA-N 0.000 description 1
- 229960000282 metronidazole Drugs 0.000 description 1
- VAOCPAMSLUNLGC-UHFFFAOYSA-N metronidazole Chemical compound CC1=NC=C([N+]([O-])=O)N1CCO VAOCPAMSLUNLGC-UHFFFAOYSA-N 0.000 description 1
- 238000003801 milling Methods 0.000 description 1
- 239000002480 mineral oil Substances 0.000 description 1
- 235000010446 mineral oil Nutrition 0.000 description 1
- 229960004023 minocycline Drugs 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 239000003607 modifier Substances 0.000 description 1
- 239000001788 mono and diglycerides of fatty acids Substances 0.000 description 1
- 229940074371 monofluorophosphate Drugs 0.000 description 1
- 235000019960 monoglycerides of fatty acid Nutrition 0.000 description 1
- 235000015861 monopotassium citrate Nutrition 0.000 description 1
- 239000002444 monopotassium citrate Substances 0.000 description 1
- HWPKGOGLCKPRLZ-UHFFFAOYSA-M monosodium citrate Chemical compound [Na+].OC(=O)CC(O)(C([O-])=O)CC(O)=O HWPKGOGLCKPRLZ-UHFFFAOYSA-M 0.000 description 1
- 235000018342 monosodium citrate Nutrition 0.000 description 1
- 239000002524 monosodium citrate Substances 0.000 description 1
- 235000019799 monosodium phosphate Nutrition 0.000 description 1
- 229910000403 monosodium phosphate Inorganic materials 0.000 description 1
- 208000030194 mouth disease Diseases 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- FYNXOZOQSPWTPU-UHFFFAOYSA-N n,2,3-trimethyl-2-propan-2-ylbutan-1-amine Chemical compound CNCC(C)(C(C)C)C(C)C FYNXOZOQSPWTPU-UHFFFAOYSA-N 0.000 description 1
- 229960004270 nabumetone Drugs 0.000 description 1
- 229960002009 naproxen Drugs 0.000 description 1
- CMWTZPSULFXXJA-VIFPVBQESA-N naproxen Chemical compound C1=C([C@H](C)C(O)=O)C=CC2=CC(OC)=CC=C21 CMWTZPSULFXXJA-VIFPVBQESA-N 0.000 description 1
- 229920001206 natural gum Polymers 0.000 description 1
- 235000021096 natural sweeteners Nutrition 0.000 description 1
- 229960004927 neomycin Drugs 0.000 description 1
- HLIAVLHNDJUHFG-HOTGVXAUSA-N neotame Chemical compound CC(C)(C)CCN[C@@H](CC(O)=O)C(=O)N[C@H](C(=O)OC)CC1=CC=CC=C1 HLIAVLHNDJUHFG-HOTGVXAUSA-N 0.000 description 1
- 235000019412 neotame Nutrition 0.000 description 1
- 108010070257 neotame Proteins 0.000 description 1
- 239000000041 non-steroidal anti-inflammatory agent Substances 0.000 description 1
- 229940021182 non-steroidal anti-inflammatory drug Drugs 0.000 description 1
- 239000002736 nonionic surfactant Substances 0.000 description 1
- 229950002404 octapinol Drugs 0.000 description 1
- 229960001774 octenidine Drugs 0.000 description 1
- SMGTYJPMKXNQFY-UHFFFAOYSA-N octenidine dihydrochloride Chemical compound Cl.Cl.C1=CC(=NCCCCCCCC)C=CN1CCCCCCCCCCN1C=CC(=NCCCCCCCC)C=C1 SMGTYJPMKXNQFY-UHFFFAOYSA-N 0.000 description 1
- ZVVSSOQAYNYNPP-UHFFFAOYSA-N olaflur Chemical compound F.F.CCCCCCCCCCCCCCCCCCN(CCO)CCCN(CCO)CCO ZVVSSOQAYNYNPP-UHFFFAOYSA-N 0.000 description 1
- 229960001245 olaflur Drugs 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- 229940092969 oral strip Drugs 0.000 description 1
- 239000011368 organic material Substances 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 235000006408 oxalic acid Nutrition 0.000 description 1
- NDLPOXTZKUMGOV-UHFFFAOYSA-N oxo(oxoferriooxy)iron hydrate Chemical compound O.O=[Fe]O[Fe]=O NDLPOXTZKUMGOV-UHFFFAOYSA-N 0.000 description 1
- BWOROQSFKKODDR-UHFFFAOYSA-N oxobismuth;hydrochloride Chemical compound Cl.[Bi]=O BWOROQSFKKODDR-UHFFFAOYSA-N 0.000 description 1
- 229960000649 oxyphenbutazone Drugs 0.000 description 1
- HFHZKZSRXITVMK-UHFFFAOYSA-N oxyphenbutazone Chemical compound O=C1C(CCCC)C(=O)N(C=2C=CC=CC=2)N1C1=CC=C(O)C=C1 HFHZKZSRXITVMK-UHFFFAOYSA-N 0.000 description 1
- LSQZJLSUYDQPKJ-UHFFFAOYSA-N p-Hydroxyampicillin Natural products O=C1N2C(C(O)=O)C(C)(C)SC2C1NC(=O)C(N)C1=CC=C(O)C=C1 LSQZJLSUYDQPKJ-UHFFFAOYSA-N 0.000 description 1
- RARSHUDCJQSEFJ-UHFFFAOYSA-N p-Hydroxypropiophenone Chemical compound CCC(=O)C1=CC=C(O)C=C1 RARSHUDCJQSEFJ-UHFFFAOYSA-N 0.000 description 1
- 239000003002 pH adjusting agent Substances 0.000 description 1
- QNGNSVIICDLXHT-UHFFFAOYSA-N para-ethylbenzaldehyde Natural products CCC1=CC=C(C=O)C=C1 QNGNSVIICDLXHT-UHFFFAOYSA-N 0.000 description 1
- 235000020232 peanut Nutrition 0.000 description 1
- 235000019477 peppermint oil Nutrition 0.000 description 1
- 239000002304 perfume Substances 0.000 description 1
- 208000028169 periodontal disease Diseases 0.000 description 1
- 230000003239 periodontal effect Effects 0.000 description 1
- 150000002978 peroxides Chemical class 0.000 description 1
- 239000003208 petroleum Substances 0.000 description 1
- 150000007965 phenolic acids Chemical class 0.000 description 1
- 235000009048 phenolic acids Nutrition 0.000 description 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 1
- 229960002895 phenylbutazone Drugs 0.000 description 1
- VYMDGNCVAMGZFE-UHFFFAOYSA-N phenylbutazonum Chemical compound O=C1C(CCCC)C(=O)N(C=2C=CC=CC=2)N1C1=CC=CC=C1 VYMDGNCVAMGZFE-UHFFFAOYSA-N 0.000 description 1
- UEZVMMHDMIWARA-UHFFFAOYSA-M phosphonate Chemical compound [O-]P(=O)=O UEZVMMHDMIWARA-UHFFFAOYSA-M 0.000 description 1
- 229910000073 phosphorus hydride Inorganic materials 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- QYSPLQLAKJAUJT-UHFFFAOYSA-N piroxicam Chemical compound OC=1C2=CC=CC=C2S(=O)(=O)N(C)C=1C(=O)NC1=CC=CC=N1 QYSPLQLAKJAUJT-UHFFFAOYSA-N 0.000 description 1
- 229960002702 piroxicam Drugs 0.000 description 1
- 239000004014 plasticizer Substances 0.000 description 1
- 229920002432 poly(vinyl methyl ether) polymer Polymers 0.000 description 1
- 239000004584 polyacrylic acid Substances 0.000 description 1
- 229920002643 polyglutamic acid Polymers 0.000 description 1
- 229940045916 polymetaphosphate Drugs 0.000 description 1
- ODGAOXROABLFNM-UHFFFAOYSA-N polynoxylin Chemical compound O=C.NC(N)=O ODGAOXROABLFNM-UHFFFAOYSA-N 0.000 description 1
- 229920005862 polyol Polymers 0.000 description 1
- 150000003077 polyols Chemical class 0.000 description 1
- 235000013824 polyphenols Nutrition 0.000 description 1
- 229920000136 polysorbate Polymers 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 235000015497 potassium bicarbonate Nutrition 0.000 description 1
- 239000011736 potassium bicarbonate Substances 0.000 description 1
- 229910000028 potassium bicarbonate Inorganic materials 0.000 description 1
- TYJJADVDDVDEDZ-UHFFFAOYSA-M potassium hydrogencarbonate Chemical compound [K+].OC([O-])=O TYJJADVDDVDEDZ-UHFFFAOYSA-M 0.000 description 1
- WKZJASQVARUVAW-UHFFFAOYSA-M potassium;hydron;2-hydroxypropane-1,2,3-tricarboxylate Chemical compound [K+].OC(=O)CC(O)(C(O)=O)CC([O-])=O WKZJASQVARUVAW-UHFFFAOYSA-M 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- 239000004405 propyl p-hydroxybenzoate Substances 0.000 description 1
- 235000010232 propyl p-hydroxybenzoate Nutrition 0.000 description 1
- QQONPFPTGQHPMA-UHFFFAOYSA-N propylene Natural products CC=C QQONPFPTGQHPMA-UHFFFAOYSA-N 0.000 description 1
- 125000004805 propylene group Chemical group [H]C([H])([H])C([H])([*:1])C([H])([H])[*:2] 0.000 description 1
- 229960003415 propylparaben Drugs 0.000 description 1
- 235000019423 pullulan Nutrition 0.000 description 1
- GYESAYHWISMZOK-UHFFFAOYSA-N quinolin-5-ol Chemical compound C1=CC=C2C(O)=CC=CC2=N1 GYESAYHWISMZOK-UHFFFAOYSA-N 0.000 description 1
- 235000009736 ragweed Nutrition 0.000 description 1
- 238000002310 reflectometry Methods 0.000 description 1
- YEXVXKIMPBHRQR-UHFFFAOYSA-N rosmarinine Natural products O1C(=O)C(=CC)CC(C)C(C)(O)C(=O)OCC2C(O)CN3C2C1CC3 YEXVXKIMPBHRQR-UHFFFAOYSA-N 0.000 description 1
- 235000015639 rosmarinus officinalis Nutrition 0.000 description 1
- 235000019204 saccharin Nutrition 0.000 description 1
- CVHZOJJKTDOEJC-UHFFFAOYSA-N saccharin Chemical compound C1=CC=C2C(=O)NS(=O)(=O)C2=C1 CVHZOJJKTDOEJC-UHFFFAOYSA-N 0.000 description 1
- 229940081974 saccharin Drugs 0.000 description 1
- 239000000901 saccharin and its Na,K and Ca salt Substances 0.000 description 1
- SJOXEWUZWQYCGL-UHFFFAOYSA-N salicylic acid menthyl ester Natural products CC(C)C1CCC(C)CC1OC(=O)C1=CC=CC=C1O SJOXEWUZWQYCGL-UHFFFAOYSA-N 0.000 description 1
- 230000007017 scission Effects 0.000 description 1
- DJSISFGPUUYILV-ZFORQUDYSA-N scutellarin Chemical compound O1[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1OC(C(=C1O)O)=CC2=C1C(=O)C=C(C=1C=CC(O)=CC=1)O2 DJSISFGPUUYILV-ZFORQUDYSA-N 0.000 description 1
- 229930190376 scutellarin Natural products 0.000 description 1
- 230000035945 sensitivity Effects 0.000 description 1
- 230000001953 sensory effect Effects 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 229940071207 sesquicarbonate Drugs 0.000 description 1
- 235000017557 sodium bicarbonate Nutrition 0.000 description 1
- UIIMBOGNXHQVGW-UHFFFAOYSA-M sodium bicarbonate Substances [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 1
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 1
- 229910000029 sodium carbonate Inorganic materials 0.000 description 1
- AJPJDKMHJJGVTQ-UHFFFAOYSA-M sodium dihydrogen phosphate Chemical compound [Na+].OP(O)([O-])=O AJPJDKMHJJGVTQ-UHFFFAOYSA-M 0.000 description 1
- GCLGEJMYGQKIIW-UHFFFAOYSA-H sodium hexametaphosphate Chemical compound [Na]OP1(=O)OP(=O)(O[Na])OP(=O)(O[Na])OP(=O)(O[Na])OP(=O)(O[Na])OP(=O)(O[Na])O1 GCLGEJMYGQKIIW-UHFFFAOYSA-H 0.000 description 1
- 235000019982 sodium hexametaphosphate Nutrition 0.000 description 1
- 229940079862 sodium lauryl sarcosinate Drugs 0.000 description 1
- 235000019333 sodium laurylsulphate Nutrition 0.000 description 1
- 235000011008 sodium phosphates Nutrition 0.000 description 1
- 229940045919 sodium polymetaphosphate Drugs 0.000 description 1
- UGTZMIPZNRIWHX-UHFFFAOYSA-K sodium trimetaphosphate Chemical compound [Na+].[Na+].[Na+].[O-]P1(=O)OP([O-])(=O)OP([O-])(=O)O1 UGTZMIPZNRIWHX-UHFFFAOYSA-K 0.000 description 1
- ADWNFGORSPBALY-UHFFFAOYSA-M sodium;2-[dodecyl(methyl)amino]acetate Chemical compound [Na+].CCCCCCCCCCCCN(C)CC([O-])=O ADWNFGORSPBALY-UHFFFAOYSA-M 0.000 description 1
- DOJOZCIMYABYPO-UHFFFAOYSA-M sodium;3,4-dihydroxy-4-oxobutanoate Chemical compound [Na+].OC(=O)C(O)CC([O-])=O DOJOZCIMYABYPO-UHFFFAOYSA-M 0.000 description 1
- DAJSVUQLFFJUSX-UHFFFAOYSA-M sodium;dodecane-1-sulfonate Chemical compound [Na+].CCCCCCCCCCCCS([O-])(=O)=O DAJSVUQLFFJUSX-UHFFFAOYSA-M 0.000 description 1
- 210000001584 soft palate Anatomy 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 229960002920 sorbitol Drugs 0.000 description 1
- 238000005507 spraying Methods 0.000 description 1
- 238000010186 staining Methods 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 230000003637 steroidlike Effects 0.000 description 1
- 150000003431 steroids Chemical class 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 229940124530 sulfonamide Drugs 0.000 description 1
- 150000003462 sulfoxides Chemical class 0.000 description 1
- 150000003467 sulfuric acid derivatives Chemical class 0.000 description 1
- 229960000894 sulindac Drugs 0.000 description 1
- MLKXDPUZXIRXEP-MFOYZWKCSA-N sulindac Chemical compound CC1=C(CC(O)=O)C2=CC(F)=CC=C2\C1=C/C1=CC=C(S(C)=O)C=C1 MLKXDPUZXIRXEP-MFOYZWKCSA-N 0.000 description 1
- 230000001629 suppression Effects 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 230000002195 synergetic effect Effects 0.000 description 1
- 239000000454 talc Substances 0.000 description 1
- 229910052623 talc Inorganic materials 0.000 description 1
- 239000011975 tartaric acid Substances 0.000 description 1
- 235000002906 tartaric acid Nutrition 0.000 description 1
- 229940095064 tartrate Drugs 0.000 description 1
- XOAAWQZATWQOTB-UHFFFAOYSA-N taurine Chemical class NCCS(O)(=O)=O XOAAWQZATWQOTB-UHFFFAOYSA-N 0.000 description 1
- 238000010998 test method Methods 0.000 description 1
- YJBKVPRVZAQTPY-UHFFFAOYSA-J tetrachlorostannane;dihydrate Chemical compound O.O.Cl[Sn](Cl)(Cl)Cl YJBKVPRVZAQTPY-UHFFFAOYSA-J 0.000 description 1
- 229960002180 tetracycline Drugs 0.000 description 1
- 229930101283 tetracycline Natural products 0.000 description 1
- 235000019364 tetracycline Nutrition 0.000 description 1
- 150000003522 tetracyclines Chemical class 0.000 description 1
- 239000001577 tetrasodium phosphonato phosphate Substances 0.000 description 1
- 229940124597 therapeutic agent Drugs 0.000 description 1
- 238000011287 therapeutic dose Methods 0.000 description 1
- YZJQPSAZKVXWEZ-UHFFFAOYSA-J tin(4+) tetraformate Chemical compound [Sn+4].[O-]C=O.[O-]C=O.[O-]C=O.[O-]C=O YZJQPSAZKVXWEZ-UHFFFAOYSA-J 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 239000010936 titanium Substances 0.000 description 1
- 229910052719 titanium Inorganic materials 0.000 description 1
- 239000004408 titanium dioxide Substances 0.000 description 1
- 229960001017 tolmetin Drugs 0.000 description 1
- UPSPUYADGBWSHF-UHFFFAOYSA-N tolmetin Chemical compound C1=CC(C)=CC=C1C(=O)C1=CC=C(CC(O)=O)N1C UPSPUYADGBWSHF-UHFFFAOYSA-N 0.000 description 1
- 210000002105 tongue Anatomy 0.000 description 1
- 235000010487 tragacanth Nutrition 0.000 description 1
- 239000000196 tragacanth Substances 0.000 description 1
- 229940116362 tragacanth Drugs 0.000 description 1
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 1
- QORWJWZARLRLPR-UHFFFAOYSA-H tricalcium bis(phosphate) Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 description 1
- 229940078499 tricalcium phosphate Drugs 0.000 description 1
- 235000019731 tricalcium phosphate Nutrition 0.000 description 1
- 229910000391 tricalcium phosphate Inorganic materials 0.000 description 1
- UNXRWKVEANCORM-UHFFFAOYSA-I triphosphate(5-) Chemical compound [O-]P([O-])(=O)OP([O-])(=O)OP([O-])([O-])=O UNXRWKVEANCORM-UHFFFAOYSA-I 0.000 description 1
- 235000019801 trisodium phosphate Nutrition 0.000 description 1
- 229910000406 trisodium phosphate Inorganic materials 0.000 description 1
- VSJRDSLPNMGNFG-UHFFFAOYSA-H trizinc;2-hydroxypropane-1,2,3-tricarboxylate;trihydrate Chemical compound O.O.O.[Zn+2].[Zn+2].[Zn+2].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O.[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O VSJRDSLPNMGNFG-UHFFFAOYSA-H 0.000 description 1
- 235000013799 ultramarine blue Nutrition 0.000 description 1
- 229940045136 urea Drugs 0.000 description 1
- 230000017260 vegetative to reproductive phase transition of meristem Effects 0.000 description 1
- 229920002554 vinyl polymer Polymers 0.000 description 1
- 235000009492 vitamin B5 Nutrition 0.000 description 1
- 239000011675 vitamin B5 Substances 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
- 239000011718 vitamin C Substances 0.000 description 1
- 235000019165 vitamin E Nutrition 0.000 description 1
- 229940046009 vitamin E Drugs 0.000 description 1
- 239000011709 vitamin E Substances 0.000 description 1
- 239000001717 vitis vinifera seed extract Substances 0.000 description 1
- 238000010792 warming Methods 0.000 description 1
- 239000009637 wintergreen oil Substances 0.000 description 1
- 239000002023 wood Substances 0.000 description 1
- 239000000230 xanthan gum Substances 0.000 description 1
- 229920001285 xanthan gum Polymers 0.000 description 1
- 235000010493 xanthan gum Nutrition 0.000 description 1
- 229940082509 xanthan gum Drugs 0.000 description 1
- 150000003751 zinc Chemical class 0.000 description 1
- 229960000314 zinc acetate Drugs 0.000 description 1
- 229940085658 zinc citrate trihydrate Drugs 0.000 description 1
- UHVMMEOXYDMDKI-JKYCWFKZSA-L zinc;1-(5-cyanopyridin-2-yl)-3-[(1s,2s)-2-(6-fluoro-2-hydroxy-3-propanoylphenyl)cyclopropyl]urea;diacetate Chemical compound [Zn+2].CC([O-])=O.CC([O-])=O.CCC(=O)C1=CC=C(F)C([C@H]2[C@H](C2)NC(=O)NC=2N=CC(=CC=2)C#N)=C1O UHVMMEOXYDMDKI-JKYCWFKZSA-L 0.000 description 1
- OXCRJCXSFXJLFS-UHFFFAOYSA-N zinc;dihypochlorite Chemical compound [Zn+2].Cl[O-].Cl[O-] OXCRJCXSFXJLFS-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/34—Alcohols
- A61K8/347—Phenols
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9783—Angiosperms [Magnoliophyta]
- A61K8/9789—Magnoliopsida [dicotyledons]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q11/00—Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Birds (AREA)
- Microbiology (AREA)
- Engineering & Computer Science (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Emergency Medicine (AREA)
- Mycology (AREA)
- Botany (AREA)
- Biotechnology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Cosmetics (AREA)
- Medicines Containing Plant Substances (AREA)
Description
[0001]本申請案主張於2004年12月17日申請之美國臨時專利申請案序號第60/637,340號之優先權,其之內容併入本文作為參考。
[0002]潔齒組成物被廣泛使用以提供口腔健康。以牙膏、漱口水、口香糖、可食條等形式之潔齒劑已藉提供使用者許多利益之各種活性物質予以調配而成。此等利益為抗菌、消炎及抗氧化劑特性。此等潔齒劑之特性使彼等成為有用之治療劑,以預防或治療許多口腔健康症狀,諸如齲齒、牙齦炎、牙菌斑、牙石、牙周疾病等。
[0003]迷迭香萃取物包括熊果酸及鼠尾草酸。於許多情況中,萃取物係分離自迷迭香(Rosmarinus officinalis
)之葉子。另一種來自迷迭香之產品,迷迭香油,係由植物之開花部分的莖萃取物和葉子衍生而來。雖然迷迭香油已被建議併同其他油類(諸如桉葉醇及薄荷腦)用於潔齒劑中,仍應注意迷迭香油之化學組成相當不同於迷迭香萃取物。
[0004]現已發現添加迷迭香萃取物於各種潔齒組成物中形成牙膏、漱口水及其他適合供治療及預防各種口腔疾病(包括牙齦炎、牙菌斑堆積等)之組成物。迷迭香萃取物,包含主要量之熊果酸及鼠尾草酸,被添加至潔齒組成物中,使當使用時被遞送至口腔之量為有效提供抗菌、抗氧化劑及/或消炎效果。於不同具體例中,迷迭香萃取物之成分與三氯生或其他酚類抗菌劑組合以提供增進之活性。
[0005]例如,牙膏通常包含以重量計約0.1至約1%或更少之迷迭香萃取物與傳統潔齒成分,諸如濕潤劑、研磨劑、抗齲齒劑、表面活性劑、芳香劑等。咀嚼膠及可食條包含相當量之迷迭香萃取物,而漱口劑及漱口水通常被調配包含較少量。
[0006]現已發現到以迷迭香萃取物成分所調配之潔齒劑在活體外及活體內均具有抗菌、消炎及/或抗氧化劑特性。
[0007]本發明之其他可應用領域由後文所提供之詳細說明將是明顯可知的。應瞭解詳細說明及特殊具實施例,雖然表示本發明之較佳具體例,但意僅供說明之目的且非用以限制本發明之範疇。
[0008]本文之"抗菌活性"意指根據任何普遍被接受之活體外或活體內之抗菌檢驗或試驗予以測量之活性。
[0009]本文之"消炎活性"意指根據任何普遍被接受之活體外或活體內之檢驗或試驗(例如供抑制前列腺素產生活環氧酶活性之檢驗或試驗)予以測量之活性。
[0010]本文之"抗氧化劑活性"意指根據任何普遍被接受之活體外或活體內之抗氧化劑檢驗或試驗予以測量之活性。
[0011]本文之"口腔表面"包含口內之任何軟或硬表面,包括舌之表面、硬及軟腭、頰黏膜、牙齦及牙表面。本文之"牙表面"為一種天然牙或人工齒列,包括牙冠、牙蓋、填充物、牙橋、假牙、牙移植物等)之硬質表面。
[0012]本文關於一種諸如於口腔組織中之發炎症狀之"抑制"一詞包含症狀之預防、壓抑、程度或嚴重性之降低或改善。
[0013]本發明之口腔組成物可採適用於口腔表面之任何形式。於不同例示具體例中,組成物可為適合供沖洗、漱口或噴霧之液體溶液;潔齒劑,諸如粉末、牙膏或牙凝膠;牙周凝膠;適合供塗刷牙表面(例如液體增白劑)之液體;咀嚼膠;可溶解、部分可溶解或不可溶解之薄膜或條(例如增白條);圓片;拭紙或毛巾;植入物;牙線等。除了上述者外,組成物可包含活性及/或載體成分。
[0014]於某些具體例中,組成物適合供應用至小型馴養動物(例如貓或狗)之口腔表面。此一組成物通常可為動物所食用或咀嚼,且可採用例如貓或狗食、加工品或玩具之形式。
[0015]成分於本文被分類作為一種活性劑或一種載體成分論述係為清楚及方便之故,不應推論特定成分必定根據其於本文之分類作用於組成物中。另外,特定成分可充當多重功能,一成分於本文中作為一功能類別實例之揭示不排除其亦可作為另一種功能類別之實例的可能。
[0016]於一具體例中,提供一種牙膏組成物,其包含至少一種濕潤劑、至少一種研磨物質及一種抗菌有效量之包含熊果酸及鼠尾草酸之抗菌成分。作為熊果酸及鼠尾草酸之一較佳來源,迷迭香萃取物於牙膏組成物中可使用之範圍涵蓋約0.01%至約5重量%,例如約0.01%至約2重量%及約0.1%至約1重量%。於不同具體例中,牙膏組成物另包含其他抗菌劑,諸如鹵化二苯醚,例如三氯生(triclosan)。
[0017]於另一具體例中,本發明提供一種抑制對象動物口腔中細菌生長之方法。該方法包含塗覆一種抗菌有效量之包含鼠尾草酸及/或熊果酸之萃取物的潔齒組成物至對象動物之口腔或口表面。於不同具體例中,潔齒組成物為牙膏、漱口水、咀嚼膠、可食條等形式。
[0018]於另一具體例中,本發明提供一種漱口水或漱口劑,包含水、香料及至少一種含氫成分,諸如乙醇、甘油及山梨醇,伴隨鼠尾草酸或鼠尾草酸與熊果酸之組合物。鼠尾草酸及/或熊果酸之較佳來源為迷迭香萃取物,例如藉迷迭香之葉的乙醇萃取物予以製備。
[0019]於另一具體例中,本發明提供一種咀嚼膠,其除了如上述之鼠尾草酸與熊果酸外,尚包含一種膠基及芳香劑。於又一具體例中,提供可食條,其除了如上述之鼠尾草酸與熊果酸外,尚包含薄膜形成聚合物及視情況選用之芳香劑。
[0020]於一方面,本發明之口腔組成物之抗菌成分包含迷迭香葉中所發現之一或多種有機化合物。有機化合物之非限制性實例包括熊果酸、鼠尾草酸、迷迭香酸、鼠尾草酚及齊墩果酸(oleanolic acid)。於一具體例中,抗菌成分包含鼠尾草酸及視情況選用之其他成分。於不同具體例中,抗菌成分為一種由迷迭香植物之葉的醇萃取所獲得之化合物之混合物。於商業具體例中,迷迭香植物之葉的萃取物由紐澤西匹茲卡塔威(Piscataway)之撒賓薩(Sabinsa)公司以迷迭香萃取物予以販售。
[0021]迷迭香萃取物包含鼠尾草酸、迷迭香酸、熊果酸、齊墩果酸及其他有機和無機物質。萃取自迷迭香葉之植物物質包含數種組成分。組成分之非限制性實例包括類黃酮,諸如香葉木素、木苷、芫花黃素、芫花黃素-4’-甲醚;6-甲氧基-芫花黃素、木犀草素、6-甲氧基木犀草素、6-甲氧基木犀草素、6-甲氧基-木犀草素-7-葡萄糖苷、6-甲氧基木犀草素-7-甲醚、粗毛豚草素、芹菜素等;酚酸,諸如迷迭香鹼及異迷迭香鹼(鼠尾草酸之反應產物);三萜酸(主要為熊果酸及齊墩果酸,含微量之19α-羥基熊果酸、2β-羥基齊墩果酸及3β-羥基脲-12,20(30)-二烯-17-酸);迷迭香酚;7-乙氧基迷迭香酚;白華脂酸;及鼠尾草酚。於不同商業具體例中,迷迭香萃取物之標準為包含最低15%之鼠尾草酸及20重量%之熊果酸。
[0022]迷迭香萃取物中有機成分之量係根據萃取過程、萃取溶劑及其他化學變數,以及植物本身之天然歧異而變動。通常,萃取物包含以重量計約10%至約40%之熊果酸及以重量計約10%至約25%之鼠尾草酸。於一較佳具體例中,萃取物包含以重量計約15%至25%之鼠尾草酸及以重量計20%至40%之熊果酸,較佳以重量計約15%至16%之鼠尾草酸及以重量計約20%至25%之熊果酸。因此,迷迭香酸包含熊果酸及鼠尾草酸作為主要成分。於不同具體例中,萃取物亦包含相對較低量之齊墩果酸,諸如約5%至15重量%。
[0023]迷迭香萃取物根據已知方法藉自迷迭香之底葉醇萃取醇可溶成分予以製備。
[0024]於不同口腔組成物中,抗菌成分之治療量被選擇以遞送有效量至口腔組成物所投與之對象動物之口腔表面。例如,於牙膏及牙凝膠中,適當濃度之抗菌成分包括約0.01重量%至約5重量%,例如0.05-5重量%,尤其約0.1-0.3重量%。在較低治療量下,組成物之抗菌及其他效果傾向於較不顯著。相反地,在較高程度之治療量下,增加用量無助於因附隨之量而增加有效性。
[0025]就牙粉而言,治療量約相同於牙膏及凝膠者,而就沖洗劑及洗劑而言,治療量傾向更低。例如,漱口劑及漱口水包含以重量計約0.01%至約2%之抗菌成分,例如約0.01%至約0.6%,約0.01%至約0.2%,及約0.01至約0.05%。此外,咀嚼膠、塗抹式組成物、可食條等傾向於以廣範圍濃度之迷迭香萃取物或鼠尾草酸予以調配。於不同具體例中,迷迭香萃取物或鼠尾草酸之用量類似於在漱口水中者。
[0026]於一方面,添加上述關於各種口腔組成物之治療量之迷迭香萃取物具有添加治療量(其係少於上述藉由個別成分所構成之重量百分比組成物所提供者)之迷迭香萃取物之主要成分(諸如鼠尾草酸及熊果酸)之效果。因此,於一具體例中,本發明提供包含約0.01重量%至5重量%治療量之鼠尾草酸的潔齒劑於口腔組成物。於其他具體例中,本發明提供口腔組成物,具有一種鼠尾草酸及熊果酸之組合物作為一種抗菌成分,使得熊果酸及鼠尾草酸成分之總治療量為如上述給定者。於一較佳具體例中,本發明之口腔組成物包含所示之用量的迷迭香萃取物。
[0027]於不同具體例中,牙膏及牙凝膠被調配包含至少一種濕潤劑、至少一種研磨物質和一種抗菌有效量之包含熊果酸及鼠尾草酸之抗菌成分。於一具體例中,組成物包含以重量計約0.01%至約5%之迷迭香萃取物,較佳以重量計約0.1%至約2%之迷迭香萃取物。於不同較佳具體例中,牙膏或牙凝膠組成物除了以重量計0.1%至約2%之迷迭香萃取物外,尚包含以重量計約1%至約70%之至少一種濕潤劑及以重量計約1%至約70%之至少一種研磨物質。
[0028]於不同具體例中,牙膏及牙凝膠組成物另包含一種抗菌劑,選自鹵化二苯醚化合物之組群。鹵化二苯醚化合物之一實例為三氯生。
[0029]牙膏及牙凝膠組成物與選擇之其他成分一起被調配,包括(但不限於)抗齲齒劑,其他抗菌劑、抗牙結石劑或牙石控制劑,陰離子羧酸鹽聚合物,黏度修飾劑、表面活性劑、香料等。
[0030]於不同具體例中,組成物包含一種口腔可接受之氟離子源,其可用作抗齲齒劑。可存在一或多種此種來源。適當之氟離子源包括氟化物、單氟磷酸鹽及氟矽酸鹽,以及胺氟化物,包括歐力氟(olaflur)(N'-十八基三亞甲基二胺-N,N,N'-三(2-乙醇)-二氫氟化物)。
[0031]一或多種氟離子-釋放鹽選擇性存在,用量為可提供總計約100至約20,000 ppm、約200至約5,000 ppm或約500至約2,500 ppm之氟離子。當氟化鈉為所存在之僅有的氟離子-釋放鹽時,例如以氟化鈉之重量計約0.01 %至約5%、約0.05%至約1%或約0.1%至約0.5%可存在於組成物中。
[0032]於另一具體例中,組成物除了上述之迷迭香成分外尚包含口腔可接受之抗微生物(例如抗菌)劑。可存在一或多種此等藥劑。
[0033]可用於本發明之酚類化合物例示性地包括(取決於口腔可接受度之測定)那些經Dewhirst(1980),前列腺素20(2),209-222,鑑定為具有消炎活性者,但不限於此。抗菌性酚類化合物之實例包括4-丙烯基兒茶酚、對羥基苯甲酸酯(包括對羥基苯甲酸苄酯、對羥基苯甲酸丁酯、對羥基苯甲酸乙酯、對羥基苯甲酸甲酯及對羥基苯甲酸丙酯)、2-苄基酚、丁基化羥基茴香醚、丁基化羥基甲苯、辣椒素、香早芹菜酚、木焦油醇、丁香油、愈創木酚、鹵化聯苯酚(包括六氯酚及溴氯酚)、4-己酯間二酚、5-羥基喹啉及其鹽類、水楊酸酯(包括水楊酸薄荷酯、水楊酸甲酯及水楊酸苯酯)、苯酚、焦兒茶酚、水楊醯替苯胺、百里香酚、三氯生及三氯生單磷酸鹽。
[0034]至少一種酚類化合物以總量約0.01%至約10%(以重量計)選擇性存在。例如,在本發明之牙膏或凝膠潔齒劑或漱口水中至少一種酚類化合物之總濃度可為約0.01%至約5%,例如約0.1%至約2%,約0.2%至約1%或約0.25%至約0.5%。
[0035]其他適合之抗菌劑包括(但不限於)銅(II)化合物(諸如銅(II)之氯化物、氟化物、硫酸鹽及氫氧化物)、鋅離子源(諸如乙酸鋅、檸檬酸鋅、葡萄糖酸鋅、甘胺酸鋅、氧化鋅、硫酸鋅及檸檬酸鋅鈉)、酞酸及其鹽(諸如酞酸單鉀鎂、己替丁(hexitidine)、辛替丁(octenidine)、血根、氯化苄烷鎓、溴化度明芬(domiphen bromide)、氯化烷基吡錠(諸如氯化鯨蠟基吡錠(CPC)(包括CPC與鋅及/或酵素之組合物)、氯化十四基吡錠及氯化N-十四基-4-乙基吡錠、碘、磺醯胺、雙-胍納得(bisguanide)(諸如亞勒西丁(alexidine)、氯己丁及氯己丁二葡萄糖酸鹽)、N-六氫吡啶基衍生物(諸如戴莫皮諾(delmopinol)及辛太皮諾(octapinol))、夜香木蘭萃取物、葡萄子萃取物、薄荷醇、牻牛兒醇、檸檬醛、桉葉醇、抗生素(諸如安滅菌(aug-mentin)、安莫西林(amoxicillin)、四環素、復力黴素(doxy-cycline)、美諾四環素(minocycline)、麥特尼唑(metroni-dazole)、新黴素(Neomycin)、卡那黴素(kanamycin)及林達黴素(lindamycin)等。可用之抗菌劑之進一步例示被提供於Gaffar等人之美國專利案第5,776,435號中,其併入本文作為參考。若存在,此等其他抗微生物劑以抗微生物有效總量存在,通常以組成物之重量計為約0.05%至約10%,例如約0.1%至約3%。
[0036]於另一具體例中,組成物包含一種口腔可接受之抗牙結石劑。可存在一或多種此種藥劑。適合之抗牙結石劑包括(但不限於)磷酸鹽及聚磷酸鹽(例如焦磷酸鹽)、聚胺基丙烷磺酸(AMPS)、檸檬酸鋅三水合物、多胜肽(諸如聚天冬胺酸及聚麩胺酸)、聚烯磺酸酯、聚烯磷酸酯、二膦酸酯,諸如氮代環烷-2,2-二膦酸酯(例如氮代環庚烷-2,2-二膦酸)、N-甲基氮代環戊烷-2,3-二膦酸、乙烷-1-羥基-1,1-二膦酸(EHDP)及乙烷-1-胺基-1,1-二膦酸酯、膦基烷羧酸及任何此等藥劑之鹽類,例如彼等之鹼金屬及銨鹽。有用之無機磷酸鹽及聚磷酸鹽例示性地包含單鹼式、二鹼式及三鹼式磷酸鈉、三聚磷酸鈉、四聚磷酸鹽、焦磷酸單-、二-、三-及四鈉、焦磷酸二氫二鈉、三偏磷酸鈉、六偏磷酸鈉等,其中鈉可選擇性地被鉀或銨取代。其他有用之抗牙結石劑包括陰離子聚羧酸鹽聚合物。陰離子聚羧酸鹽聚合物包含羧基於一碳骨架上且包括丙烯酸、甲基丙烯酸及順丁烯二酸酐之聚合物或共聚物,非限制性實例包括聚乙烯甲酯/順丁烯二酸酐(PVME/MA)共聚物,諸如那些可得自ISP(Wayne,NJ)之GantrezT M
品牌者。其他有用之抗牙結石劑包括鉗合劑,包括羥基羧酸鹽,諸如檸檬酸、反丁烯二酸、蘋果酸、戊二酸及草酸及其鹽類,及胺基聚羧酸,諸如乙二胺四乙酸(EDTA)。一或多種抗牙結石劑選擇性地以抗牙結石有效總量存在於組成物中,通常以重量計為約0.01%至約50%,例如約0.05%至約25%或約0.1%至約15%。
[0037]於不同具體例中,抗牙結石系統包含一種三聚磷酸鈉(STPP)和焦磷酸四鈉(TSPP)之混合物。於不同具體例中,TSPP對STPP之比例為約1:2至約1:4。於一較佳具體例中,第一抗牙結石活性成分TSPP存在約1至約2.5 %,第二抗牙結石活性成分STPP存在約1至約10%。
[0038]於一較佳具體例中,陰離子聚羧酸鹽聚合物存在約0.1%至約5%。於另一具體例中,陰離子聚羧酸鹽聚合物存在約0.5%至約1.5%,最佳為口腔護理組成物之約1 %。於根據本發明之一具體例中,抗牙結石系統包含順丁烯二酸酐和甲基乙烯醚之共聚物,諸如上述之Gantrez S-97產品。
[0039]於不同具體例中,TSPP對STPP對合成陰離子聚羧酸鹽之比例,其範圍為約5:10:1至約5:20:10(或1:4:2)。於一具體例中,口腔護理組成物之抗牙結石系統包含1:7:1比例之TSPP、STPP及聚羧酸鹽,諸如順丁烯二酸酐和甲基乙烯醚之共聚物。於非限制性具體例中,抗牙結石系統實質上由約0.5%至約2.5%之TSPP、約1%至約10%之STPP及約0.5%至約1.5%之順丁烯二酸酐和甲基乙烯醚之共聚物所組成。
[0040]於另一具體例中,組成物包含一種可用於例如幫助降低牙齦炎、牙菌斑、牙結石、齲齒或敏感性之口腔可接受之錫離子源。可存在一或多種此種來源。適當之錫離子源包括(但不限於)氟化錫、其他鹵化錫(諸如氯化錫二水合物)、焦磷酸錫、有機錫羧酸鹽(諸如甲酸錫、乙酸鹽、葡萄糖酸鹽、乳酸鹽、酒石酸鹽、草酸鹽、丙二酸及檸檬酸鹽)、乙二醇化錫等。一或多種錫離子源選擇性及例示性地存在,總量以組成物之重量計為約0.01%至約10%,例如約0.1%至約7%或約1%至約5%。
[0041]於另一具體例中,組成物包含一種例如可用作抗微生物、抗牙結石或呼吸清新劑之口腔可接受鋅離子源。可存在一或多種此種來源。適合之鋅離子源包括(但不限於)乙酸鋅、檸檬酸鋅、葡萄糖酸鋅、甘胺酸鋅、氧化鋅、硫酸鋅、檸檬酸鋅鈉等。一或多種鋅離子源選擇性及例示性地存在,總量以組成物之重量計為約0.05%至約3%,例如約0.1%至約1%。
[0042]於另一具體例中,組成物包含一種口腔可接受之呼吸清新劑。一或多種此等藥劑以呼吸清新有效總量存在。適當之呼吸清新劑包括(但不限於)鋅鹽,諸如葡萄糖酸鋅、檸檬酸鋅及次氯酸鋅、α-紫羅酮(ionone)等。
[0043]於另一具體例中,組成物包含一種口腔可接受之抗牙菌斑劑,包括牙菌斑分裂劑。一或多種此種藥劑以抗牙菌斑有效總量存在。適當之抗牙菌斑劑包括(但不限於)錫、銅、鎂及鍶鹽、二甲基聚矽氧烷共多元醇(諸如鯨蠟基二甲基聚矽氧烷共多元醇)、木瓜酵素、葡萄糖澱粉酶、葡萄糖氧化酶、尿素、乳酸鈣、甘油磷酸鈣、聚丙烯酸鍶及螯合劑,諸如檸檬酸及酒石酸及其之鹼金屬鹽。
[0044]於另一具體例中,組成物除了上述之迷迭香成分外尚包含一種口腔可接受之消炎劑。一或多種此種藥劑以消炎有效總量存在。適當之消炎劑包括(但不限於)類固醇藥劑,諸如氟輕松(flucinolone)及氫可體松及非類固醇藥劑(NSAIDs),諸如凱特羅雷克(ketorolac)、氟比布洛芬(flurbiprofen)、依布洛芬(ibuprofen)、那波辛(naproxen)、消炎痛(indomethacin)、克羅風(diclofenac)依拖多雷克(etodolac)、消炎痛(indomethacin)、蘇靈酸(sulindac)、拖麥丁(tolmetin)、酮洛芬(ketoprofen)、芬諾洛芬(feno-profen)、吡咯西凱(piroxicam)、那布米酮(nabumetone)、阿斯匹靈、二夫那(diflunisal)、麥可芬那(meclodenamate)、甲芬那酸(mefenamicacid)、氧苯丁腙(oxyphenbutazone)及苯基丁腙(phenylbutazone)。一或多種消炎劑選擇性地以消炎有效量存在於組成物中。
[0045]本發明之組成物可包含其他成分,諸如酵素、維生素及抗黏附劑。諸如蛋白酶之酵素被添加供防著色及其他效果。維生素之非限制性實例包括維生素C、維生素E;維生素B5及葉酸。於不同具體例中,維生素具有抗氧化特性。抗黏附劑包括索伯(solbrol)、無花果酵素及群數感應抑制劑。
[0046]供選擇性包含於本發明組成物中之有用載體為稀釋劑、研磨劑、碳酸氫鹽、pH修飾劑、表面活性劑、泡沫調整劑、增稠劑、黏度修飾劑、濕潤劑、甜味劑、芳香劑及著色劑。一種載體物質,或多於一種相同或不同類別之載體物質可選擇性存在。載體應選擇互相相容或與組成物之其他成分相容者。
[0047]水是一種較佳的稀釋劑且於某些組成物(諸如漱口水及增白液)中通常伴隨著醇,例如乙醇。漱口水組成物中水對醇之重量比通常為約1:1至約20:1,例如約3:1至約20:1或約4:1至約10:1。於一種增白液中,水對醇之重量比可在上述範圍之內或之下,例如約1:10至約2:1。
[0048]於一具體例中,本發明之組成物包含至少一種研磨劑,例如可用作光亮劑。可使用任何口腔可接受之研磨劑,但研磨劑之種類、細度(粒度)及用量應經選擇,使得在正常使用組合物下,不會過度磨蝕牙齒琺瑯質。適當之研磨劑包括(但不限於)矽石、礬土、不可溶磷酸鹽、碳酸鈣、樹脂型研磨劑,諸如脲-甲醛縮合產物等。可用作研磨劑之不可溶磷酸鹽為正磷酸鹽、聚偏磷酸鹽及焦磷酸鹽。例示性實施例為二水合磷酸二鈣、焦磷酸鈣、焦磷酸β-鈣、磷酸三鈣、聚偏磷酸鈣及不可溶聚偏磷酸鈉。一或多種研磨劑選擇性以研磨有效總量存在,通常以組成物之重量計為約5%至約70%,例如約10%至約50%,或約15%至約30%。若存在,研磨劑之平均粒徑通常為約0.1至約30微米,例如約1至約20微米或約5至約15微米。
[0049]於又一具體例中,本發明之組成物包含至少一種碳酸氫鹽,可用於因起泡及釋放二氧化碳而賦予牙齒“清潔感”。可使用任何口腔可接受之碳酸氫鹽,包括(但不限於)鹼金屬碳酸氫鹽,諸如碳酸氫鹽鈉及鉀、碳酸氫鹽銨等。一或多種碳酸氫鹽選擇性地存在,總量以組成物之重量計為0.1%至約50%,例如約1%至約20%。
[0050]於再一具體例中,本發明之組成物包含至少一種pH修飾劑。此等藥劑包括降低pH之酸化劑、提高pH之鹼化劑及可控制pH於期望範圍內之緩衝劑。例如,可包括選自酸化劑、鹼化劑及緩衝劑之一或多種化合物以提供pH約2至約10,或於一不同之例示具體例中,約2至約8,約3至約9,約4至約8,約5至約7,約6至約10,約7至約9等。可使用任何口腔可接受之pH修飾劑,包括(但不限於)羧酸、磷酸及硫酸、酸性鹽(例如檸檬酸一鈉、檸檬酸二鈉、蘋果酸一鈉等)、鹼金屬氫氧化物(諸如氫氧化鈉)、碳酸鹽(諸如碳酸鈉)、碳酸氫鈉、倍半碳酸鹽、硼酸鹽、矽酸鹽、磷酸鹽(諸如磷酸一鈉、磷酸三鈉、焦磷酸鹽等)、咪唑等。一或多種pH修飾劑選擇性地以有效維持組成物於口腔可接受之pH範圍內之總量存在。
[0051]於又一具體例中,本發明之組成物包含至少一種表面活性劑,可用於例如與組成物之其他成分相容,藉此提供增進之穩定性以幫助經由清潔程序清潔牙表面,且當以本發明之潔齒組成物攪拌時(例如在刷牙期間)提供泡沫。可使用任何口腔可接受之表面活性劑,其大多數為陰離子性、非離子性及兩性離子型。適合之陰離子表面活性劑包括(但不限於)C8 - 2 0
烷基硫酸鹽之水可溶鹽、C8 - 2 0
脂肪酸之磺酸化單甘油酯、肌胺酸鹽、牛磺酸鹽等。此等及其他類別之例示性實例包括月桂基硫酸鈉、椰子單甘油酯磺酸鈉、月桂基肌胺酸鈉、月桂基異磺乙硫酸鈉、月桂醇醚基羧酸鈉及十二烷基苯磺酸鈉。適合之非離子表面活性劑包括(但不限於)普洛沙瑪(poloxomer)、聚氧乙烯去水山梨醇酯、脂肪醇乙氧化物、烷基苯酚乙氧化物、第三胺氧化物、第三氧化膦、二烷基亞碸等。適合之兩性表面活性劑包括(但不限於)具有陰離子基團之C8 - 2 0
脂族第二及第三胺鏈之衍生物,諸如羧酸鹽、硫酸鹽、磺酸鹽、磷酸鹽或膦酸鹽。適當之實例包括椰子醯胺基丙基甜菜鹼。一或多種表面活性劑選擇性地存在,總量以組成物之重量計為約0.01至約10%,例如約0.05%至約5%或約0.1%至約2%。
[0052]於又一具體例中,本發明之組成物包含至少一種可用於例如增加組成物於攪拌時所產生之泡沫的用量、厚度或穩定性之泡沫調整劑。可使用任何口腔可接受之泡沫調整劑,包括(但不限於)聚乙二醇(PEGs),亦已知為聚氧乙烯。高分子量PEGs為適合者,包括那些具有平均分子量約200,000至約7,000,000,例如約500,000至約5,000,000或約1,000,000至約2,500,000。一或多種PEGs選擇性地存在,總量以組成物之重量計為約0.1%至約10%,例如約0.2%至約5%或約0.25%至約2%。
[0053]於再一具體例中,本發明之組成物包含至少一種可用於例如賦予組成物期望之黏稠度及/或口感之增稠劑。可使用任何口腔可接受之增稠劑,包括(但不限於)卡巴摩耳(carbomer)(亦已知為羧基乙烯聚合物)、鹿角菜膠(亦已知為愛爾蘭苔,且尤特別為τ-鹿角菜膠)、纖維素性聚合物(諸如羥基乙基纖維素、羧基甲基纖維素(CMC)及其鹽類(例如CMC鈉))、天然膠(諸如卡拉亞(karaya)、黃原膠、阿拉伯膠及黃耆膠)、膠體矽酸鎂、膠體矽石等。一或多種增稠劑選擇性地存在,總量以組成物之重量計為約0.01%至約15%,例如約0.1%至約10%或約0.2%至約5%。
[0054]於又一具體例中,本發明之組成物包含至少一種可用於例如抑制成分之沉澱或分離,或促進於攪拌液體組成物時之再分散性之黏度修飾劑。可使用任何口腔可接受之黏度修飾劑,包括(但不限於)礦物油、石油、黏土及有機改質黏土、矽石等。一或多種黏度修飾劑選擇性存在,總量以組成物之重量計為約0.01%至約10%,例如約0.1%至約5%。
[0055]於再一具體例中,本發明之組成物包含至少一種可用於例如避免牙膏當曝露於空氣中時硬化之濕潤劑。可使用任何口腔可接受之濕潤劑,包括(但不限於)多元醇,諸如甘油、山梨醇、木糖醇、或低分子量PEGs。大多數之濕潤劑可充作甜味劑。一或多種濕潤劑選擇性地存在,總量以組成物之重量計為約1%至約70%,例如約1%至約50%、約2%至約25%或約5%至約15%。
[0056]於再一具體例中,本發明之組成物包含至少一種可用於例如增進組成物之味道之甜味劑。可使用任何口腔可接受之天然或人造甜味劑,包括(但不限於)右旋糖、蔗糖、麥芽糖、糊精、乾燥反轉糖、甘露糖、木糖、核糖、果糖、左旋糖、半乳糖、玉米糖漿(包括高果糖糖漿及玉米糖漿固體)、部分水解澱粉、氫化澱粉水解物、山梨醇、甘露糖醇、木糖醇、麥芽糖醇、異麥芽糖、阿斯巴甜、新坦(neotame)、糖精及其鹽、以胜肽為底之強力甜味劑、賽克拉美等。一或多種甜味劑選擇性地存在,總量嚴格視所選擇之特定甜味劑而定,但以組成物之重量計通常為約0.005%至約5%。
[0057]於再一具體例中,本發明之組成物包含至少一種可用於增進組成物味道之芳香劑。可使用任何口腔可接受之天然或合成之芳香劑,包括(但不限於)香草、鼠尾草、墨角藍、芫荽油、留蘭香油、肉桂油、冬青油(水楊酸甲酯)、薄荷油、丁香油、野月桂油、大茴香油、桉葉油、柑橘油、水果油及油精,包括那些衍生自檸檬、橘子、萊姆、葡萄柚、杏、香蕉、葡萄、蘋果、草莓、櫻桃、鳳梨等者、豆-及核果-衍生之芳香劑(諸如咖啡、可可、可樂子、花生、杏仁等)、吸附及包封之芳香劑及彼等之混合物。亦包含於本文之芳香劑中者為提供芳香及/或其他口中感官效果(包括清涼或溫暖效果)之成分。此等成分例如包括薄荷醇、乙酸薄荷酯、乳酸薄荷酯、樟腦、桉葉油、桉葉醇、茴香醚、丁香酚、木犀、覆盆子酮甲醚(oxanone)、α-環檸檬叉丙酮、丙烯基癒創酚、百里香酚、芳樟醇、苯甲醛、肉桂醛、N-乙基-對-薄荷基-3-羧醯胺、N,2,3-三甲基-2-異丙基丁醯胺、3-(1-薄荷氧基)-丙烷-1,2-二醇、肉桂醛甘油縮醛(CGA)、薄荷酮甘油縮醛(MGA)及彼等之混合物。一或多種芳香劑選擇性之存在總量以組成物之重量計為約0.01%至約5%,例如約0.1%至約2.5%。
[0058]於再一具體例中,本發明之組成物包含至少一種著色劑。本文之著色劑包括顏料、染料、色澱染料及賦予特殊光澤及反射性之藥劑(諸如珠光劑)。著色劑可提供各種功能(包括例如提供牙表面白色或淡色塗料),以作為已被組成物有效接觸之牙表面區域之指示劑及/或修飾組成物外觀,特別是顏色及/或不透明性,用以增進對消費者之吸引力。可使用任何口腔可接受之著色劑,包括(但不限於)滑石、雲母、碳酸鎂、碳酸鈣、矽酸鎂、矽酸鋁鎂、矽石、二氧化鈦、氧化鋅、紅色、黃色、棕色及黑色氧化鐵氰化亞鐵鐵銨、錳紫、群青、含鈦石雲母、氧氯化鉍等。一或多種著色劑選擇性地存在,總量以組成物之重量計為約0.001%至約20%,例如約0.01%至約10%或約0.1%至約5%。
[0059]於另一具體例中,提供漱口劑或漱口水組成物,其包含水、一或多種如上述之芳香劑、一或多種有機氫化合物及一種抗菌有效量之如上述之抗菌組成物。於不同具體例中,漱口劑或漱口水組成物包含以重量計由0.001%至約5%之包含熊果酸及鼠尾草酸之植物(諸如迷迭香)之葉的醇萃取物。於一較佳具體例中,組成物包含以重量計約0.01%至約1%之迷迭香萃取物。一或多種有機氫化合物為口腔可接受之有機溶劑,諸如(但不限於)乙醇及甘油。選擇地,漱口劑或漱口水組成物包含一種表面活性劑以幫助芳香劑及抗菌組成物之分散。
[0060]於不同具體例中,本發明提供咀嚼膠組成物,其包含膠基及如上述之抗菌有效量之抗菌有效組成物。此外,咀嚼膠調配物通常包含一或多種塑化劑、至少一種甜味劑及至少一種芳香劑。
[0061]膠基材料為此技藝中已知且包括天然或合成膠基或其之混合物。代表性之天然膠或彈性體包括糖膠樹膠、天然橡膠、南洋桐、橡皮膠、馬來樹膠、萊奇蓋思匹(lechi caspi)、蘇瓦(sorva)、古塔凱(gutta kay)、冠膠及皮利羅(perillo)。合成膠或彈性體包括丁二烯-苯乙烯共聚物、聚異丁烯及異丁烯-異戊二烯共聚物。膠基以約10至約40%,較佳約20至約35%之濃度被混入咀嚼膠產品中。
[0062]於其他具體例中,口腔組成物包含一種可食性口腔條,其包含一或多種聚合性成膜劑和如上述之抗菌有效量之抗菌有效組成物。一或多種聚合性成膜劑選自由口腔可接受之聚合物(諸如普魯蘭膠(pullulan)、纖維素衍生物)及其他可溶性聚合物(包括那些此技藝中為人所熟知者)所組成之組群中。
[0063]於不同具體例中,本發明之牙膏或凝膠組成物包含迷迭香萃取物、至少一種濕潤劑、以矽石為底之研磨化合物及選擇之抗牙結石劑。抗牙結石劑選擇性包含如上述之聚陰離子羧酸鹽。選擇地,組成物包含抗齲齒劑,諸如氟化鈉、氟化錫、單氟磷酸鹽等。除了濕潤劑外,組成物尚包含以重量計約1%至約40%之水。
[0064]於不同具體例中,根據例如在人造口抗牙菌斑研究中所顯示,組成物可有效抵抗口腔細菌之組合。於不同具體例中,相較於不含抗菌組成物之負性控制組,可見到牙菌斑發展之顯著降低。
[0065]於不同具體例中,組成物亦顯示抗氧化劑特性,例如根據在以調配之潔齒劑所進行之LPO-CC檢驗中所證實者,及/或亦顯示體內之臨床有效性。例如,在較佳具體例中,本發明之組成物在改良之牙齦邊緣牙菌斑指數測定中顯示抗牙齦效能。試驗程序(熟知為MGMPI)已被公開。包括有效量迷迭香萃取物之組成物顯示超越負性控制組之顯著改良。於其他具體例中,本發明之組成物根據短期臨床研究所證實者,亦可有效抵抗牙菌斑。
[0066]於不同具體例中,本發明部分係基於發現到當諸如在迷迭香萃取物中所發現之成分被添加至包含抗菌有效量之鹵化二苯醚之潔齒組成物時,可促進潔齒組成物之消炎效果。因此,本發明於不同具體例中提供包含迷迭香萃取物和鹵化二苯醚(諸如但不限於三氯生、三氯生單磷酸鹽及2,2’-二羥基-5,5’-二溴二苯醚)之潔齒組成物。
[0067]因此,於不同具體例中,本發明之組成物除了諸如迷迭香萃取物之抗菌成分外,尚包含一種選自二苯醚組群之抗微生物劑。於一較佳具體例中,二苯醚化合物為三氯生。現已發現到迷迭香萃取物不會干擾鹵化二苯醚化合物之抗微生物活性。尤其,於一較佳具體例中,迷迭香萃取物不會干擾經調配牙膏中三氯生之可利用性。
[0068]包含迷迭香萃取物及二苯醚化合物之組成物的有效性亦於人造口研究中被證實,其相對於含有單獨二苯醚化合物之組成物顯示改良之抗牙菌斑效能。
[0069]包含迷迭香萃取物及二苯醚化合物(諸如三氯生)之組成物,於較佳具體例中,相較於不含迷迭香萃取物之組成物,顯示增進之消炎效果。於一較佳具體例中,經例如前列腺素E2酵素免疫檢驗(PGE2)所證實,在迷迭香萃取物與二苯醚化合物(諸如三氯生)之間有協乘效果。
[0070]於不同具體例中,迷迭香萃取物添加至包含二苯醚化合物之口腔組成物中,亦經例如LPO-CC抗氧化劑檢驗所證實,顯示增加口腔組成物之抗氧化劑特性。最後,迷迭香萃取物組合於包含二苯醚化合物(諸如三氯生)之口腔組成物中業經證實在臨床牙齦炎及牙菌斑研究中可改良效能。
實施例1-不含聚陰離子羧酸鹽聚合物之潔齒劑調配物
[0071]組成物於活體外及活體內試驗顯示抗菌、抗牙菌斑、抗牙齦炎效能。
實施例2-含聚陰離子羧酸鹽聚合物之潔齒劑
[0072]組成物顯示抗牙菌斑及抗牙齦炎效能。
實施例3-漱口水組成物表4
實施例5-抗牙菌斑效能[0073]實施例1及2之組成物在人造口檢驗中顯示抗牙菌斑效能。例如,在0.2%之迷迭香萃取物下,組成物相對於負性控制組顯示54%牙菌斑降低。
實施例6-抗氧化劑有效性[0074]實施例1及2之組成物在LPO-CC(脂肪過氧化物)檢驗中顯示抗氧化劑效能。負性控制組提供約0.81之光學密度,當以0.3重量%之迷迭香萃取物調配時,實施例1提供約0.72,實施例2提供約0.74。
實施例7a-含三氯生之潔齒劑組成物
[0075]上述成分被調配成一種潔齒劑。
實施例7b-此組成物類似實施例7a,但不含三氯生。
實施例7c-此組成物類似實施例7a,但不含迷迭香萃取物。
實施例8-具有0.2%迷迭香萃取物之實施例7a之組成物在臨床牙齦炎及牙菌斑研究中,相較於實施例9之組成物顯示改良效能。
實施例9-實施例7a之組成物相較於類似實施例7b或7c之組成物,顯示改良之消炎效果。
[0076]本發明已參照例示實施例詳細說明如上,惟應瞭解本發明並非限於所揭露之具體例。熟悉此項技藝者當閱讀本說明書時可思及之變化及修飾亦在本發明於附隨之申請專利範圍所限定之範疇內。
Claims (8)
- 一種牙膏組成物,其包含:至少一種濕潤劑;至少一種研磨物質;一種含釋氟化合物之抗齲齒劑,一種含0.1至2重量%之迷迭香萃取物之抗菌成分,其中該迷迭香萃取物包含熊果酸及鼠尾草酸;一種含有0.01至5重量%三氯生之抗菌劑;及一種陰離子聚羧酸鹽聚合物。
- 根據申請專利範圍第1項之組成物,包含1至70重量%之至少一種濕潤劑及1至70重量%之至少一種研磨物質。
- 根據申請專利範圍第1項之組成物,其中該至少一種濕潤劑係選自由甘油、丙二醇及山梨醇所組成之組群。
- 一種牙膏組成物,包含0.01至5重量%之三氯生;0.1至2重量%之迷迭香萃取物,1至70重量%之濕潤劑,及1至70重量%之至少一種研磨物質。
- 根據申請專利範圍第4項之組成物,另包含一種陰離子聚羧酸鹽聚合物。
- 一種潔齒組成物,其為一種漱口水或漱口劑組成物,包含0.1至2重量%之迷迭香萃取物、0.01至5重量%之三氯生、一或多種芳香劑、水、及一或多種選自由乙醇、甘油、山梨醇及丙二醇所成組群之氫化合物。
- 一種潔齒組成物,其為一咀嚼膠組成物,包含膠基、0.1至2重量%之迷迭香萃取物、及0.01至5重量%之三氯生。
- 一種潔齒組成物,其為一種可食條形式,包含一或多種成膜聚合物、可食條之總重量計0.1至2%之迷迭香萃取物及0.01至5重量%之三氯生。
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US63734004P | 2004-12-17 | 2004-12-17 | |
| US11/256,861 US20060134025A1 (en) | 2004-12-17 | 2005-10-24 | Oral compositions containing extracts of Rosmarinus and related methods |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| TW200637605A TW200637605A (en) | 2006-11-01 |
| TWI399221B true TWI399221B (zh) | 2013-06-21 |
Family
ID=36264019
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| TW094144587A TWI399221B (zh) | 2004-12-17 | 2005-12-16 | 含有迷迭香萃取物之口腔組成物及相關方法 |
Country Status (16)
| Country | Link |
|---|---|
| US (1) | US20060134025A1 (zh) |
| EP (1) | EP1824566B1 (zh) |
| AR (1) | AR052057A1 (zh) |
| AT (1) | ATE457781T1 (zh) |
| AU (1) | AU2005316919B2 (zh) |
| BR (1) | BRPI0519925B1 (zh) |
| CA (1) | CA2590223C (zh) |
| DE (1) | DE602005019461D1 (zh) |
| DK (1) | DK1824566T3 (zh) |
| ES (1) | ES2340054T3 (zh) |
| MX (1) | MX2007007249A (zh) |
| MY (1) | MY148458A (zh) |
| PL (1) | PL1824566T3 (zh) |
| RU (1) | RU2388456C2 (zh) |
| TW (1) | TWI399221B (zh) |
| WO (1) | WO2006065522A2 (zh) |
Families Citing this family (61)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8268371B2 (en) * | 2005-08-22 | 2012-09-18 | Kraft Foods Global Brands Llc | Degradable chewing gum |
| US8282971B2 (en) * | 2005-08-22 | 2012-10-09 | Kraft Foods Global Brands Llc | Degradable chewing gum |
| US20070042079A1 (en) * | 2005-08-22 | 2007-02-22 | Cadbury Adams Usa Llc | Environmentally-friendly chewing gum having reduced stickiness |
| US20070042078A1 (en) * | 2005-08-22 | 2007-02-22 | Cadbury Adams Usa Llc | Biodegradable chewing gum |
| US8287928B2 (en) | 2005-08-22 | 2012-10-16 | Kraft Foods Global Brands Llc | Degradable chewing gum |
| US8263143B2 (en) | 2005-08-22 | 2012-09-11 | Kraft Foods Global Brands Llc | Degradable chewing gum |
| US20070140990A1 (en) | 2005-12-21 | 2007-06-21 | Nataly Fetissova | Oral Compositions Comprising Propolis |
| JP5166260B2 (ja) | 2006-06-19 | 2013-03-21 | 株式会社クラレ | トリテルペン酸を含む皮膚外用剤 |
| GB0623618D0 (en) * | 2006-11-27 | 2007-01-03 | Mars Uk Ltd | Composition |
| DE102006061287A1 (de) * | 2006-12-22 | 2008-06-26 | Lts Lohmann Therapie-Systeme Ag | Eßbare folienförmige Zubereitung mit Cola-Geschmack |
| CN101883573B (zh) | 2007-10-01 | 2013-03-13 | 高露洁-棕榄公司 | 含有植物提取物的口腔组合物 |
| AR074309A1 (es) * | 2008-11-10 | 2011-01-05 | Glaxosmithkline Llc | Compuestos anti-inflamatorios y sus composiciones farmaceuticas, dentifricas y adhesivas. metodo |
| WO2010132776A1 (en) * | 2009-05-14 | 2010-11-18 | Rutgers, The State University Of New Jersey | Oregano and mint anti-inflammatory compositions and methods |
| EA200900764A1 (ru) * | 2009-05-15 | 2010-04-30 | Общество С Ограниченной Ответственностью "Вдс" | Состав для профилактики стоматологических заболеваний |
| IN2012DN02657A (zh) | 2009-10-29 | 2015-09-11 | Colgate Palmolive Co | |
| CN102762259A (zh) | 2009-12-04 | 2012-10-31 | 高露洁-棕榄公司 | 含有倒捻子提取物的口腔组合物及相关方法 |
| MY150829A (en) | 2009-12-04 | 2014-02-28 | Colgate Palmolive Co | Oral compositions containing extracts of myristica fragrans and related methods |
| EP2506934A1 (en) | 2009-12-04 | 2012-10-10 | Colgate-Palmolive Company | Oral compositions containing extracts of zizyphus joazeiro and related methods |
| JP2013512905A (ja) | 2009-12-04 | 2013-04-18 | コルゲート・パーモリブ・カンパニー | ジンギベル・オフィキナレの抽出物を含有する口腔用組成物および関連する方法 |
| BR112012013345A2 (pt) | 2009-12-04 | 2016-03-01 | Colgate Palmolive Co | composições orais contendo uma combinação de extratos naturais e métodos relacionados |
| TWI382852B (zh) | 2009-12-22 | 2013-01-21 | Univ Taipei Medical | 一種口腔保健用磷酸鈣複合物及其製法與組合物 |
| US8715625B1 (en) | 2010-05-10 | 2014-05-06 | The Clorox Company | Natural oral care compositions |
| US9539445B2 (en) | 2010-11-22 | 2017-01-10 | Taipei Medical University | Type of anion-containing calcium phosphate compound for dental remineralization |
| SG190843A1 (en) * | 2010-12-13 | 2013-07-31 | Colgate Palmolive Co | Oral compositions |
| AU2010365416B2 (en) * | 2010-12-13 | 2015-05-28 | Colgate-Palmolive Company | Oral compositions and method for producing thereof |
| HK1203432A1 (zh) * | 2011-12-20 | 2015-10-30 | Colgate-Palmolive Company | 口腔護理組合物 |
| JP6077306B2 (ja) * | 2013-01-04 | 2017-02-08 | 長瀬産業株式会社 | 美白用皮膚外用組成物 |
| US10105296B2 (en) | 2013-04-23 | 2018-10-23 | Rita Vaccaro | Thin film toothpaste strip |
| US9656102B2 (en) * | 2013-04-23 | 2017-05-23 | Rita Vaccaro | Thin film toothpaste strip |
| MX373205B (es) | 2013-12-16 | 2020-05-04 | Nutrition & Biosciences Usa 4 Inc | Uso de eteres de poli-alfa-1,3-glucano como modificadores de la viscosidad. |
| WO2015095358A1 (en) | 2013-12-18 | 2015-06-25 | E. I. Du Pont De Nemours And Company | Cationic poly alpha-1,3-glucan ethers |
| EP3105256A1 (en) | 2014-02-14 | 2016-12-21 | E. I. du Pont de Nemours and Company | Poly-alpha-1,3-1,6-glucans for viscosity modification |
| ES2734726T3 (es) | 2014-03-11 | 2019-12-11 | Du Pont | Poli alfa-1,2-glucano oxidado como reforzante de detergente |
| US9714403B2 (en) | 2014-06-19 | 2017-07-25 | E I Du Pont De Nemours And Company | Compositions containing one or more poly alpha-1,3-glucan ether compounds |
| EP3919599A1 (en) | 2014-06-19 | 2021-12-08 | Nutrition & Biosciences USA 4, Inc. | Compositions containing one or more poly alpha-1,3-glucan ether compounds |
| EP3237631A1 (en) | 2014-12-23 | 2017-11-01 | E. I. du Pont de Nemours and Company | Enzymatically produced cellulose |
| WO2016160738A2 (en) | 2015-04-03 | 2016-10-06 | E I Du Pont De Nemours And Company | Gelling dextran ethers |
| JP7064435B2 (ja) | 2015-11-26 | 2022-05-10 | ニュートリション・アンド・バイオサイエンシーズ・ユーエスエー・フォー,インコーポレイテッド | α-1,2-分岐鎖を有するグルカンを生成することができるポリペプチドおよびその使用 |
| WO2018011790A1 (en) * | 2016-07-11 | 2018-01-18 | The State Of Israel, Ministry Of Agriculture & Rural Development, Agricultural Research Organization (Aro), (Volcani Center) | Treatment of follicular tonsillitis with plant extracts containing carnosic acid |
| EP4467599A3 (en) | 2017-12-14 | 2025-04-23 | Nutrition & Biosciences USA 4, Inc. | Alpha-1,3-glucan graft copolymers |
| CN113574074B (zh) | 2018-10-25 | 2023-03-21 | 营养与生物科学美国第四公司 | α-1,3-葡聚糖接枝共聚物 |
| CN109480049A (zh) * | 2018-12-27 | 2019-03-19 | 白昀易 | 口香糖及其制备方法 |
| CA3140627A1 (en) * | 2019-05-31 | 2020-12-03 | Colgate-Palmolive Company | Oral care composition |
| EP3999023A4 (en) * | 2019-08-23 | 2023-07-05 | Colgate-Palmolive Company | METHODS OF INTEGRATION OF OLEANOLIC ACID INTO ORAL CARE COMPOSITIONS AND ORAL CARE COMPOSITIONS CONTAINING THEM |
| JP2023500323A (ja) | 2019-11-06 | 2023-01-05 | ニュートリション・アンド・バイオサイエンシーズ・ユーエスエー・フォー,インコーポレイテッド | 高結晶質アルファ-1,3-グルカン |
| WO2021158543A1 (en) | 2020-02-04 | 2021-08-12 | Nutrition & Biosciences USA 4, Inc. | Aqueous dispersions of insoluble alpha-glucan comprising alpha-1,3 glycosidic linkages |
| BR112022024705A2 (pt) | 2020-06-04 | 2023-02-28 | Nutrition & Biosciences Usa 4 Inc | Composição, método para produzir um composto de éter ou éster de copolímero de enxerto, método de floculação e método de absorção |
| EP4294849A1 (en) | 2021-02-19 | 2023-12-27 | Nutrition & Biosciences USA 4, Inc. | Polysaccharide derivatives for detergent compositions |
| JP2024517798A (ja) | 2021-05-04 | 2024-04-23 | ニュートリション・アンド・バイオサイエンシーズ・ユーエスエー・フォー,インコーポレイテッド | 不溶性アルファ-グルカンを含む組成物 |
| JP2024525685A (ja) | 2021-07-13 | 2024-07-12 | ニュートリション・アンド・バイオサイエンシーズ・ユーエスエー・フォー,インコーポレイテッド | カチオン性グルカンエステル誘導体 |
| US20250002695A1 (en) | 2021-11-05 | 2025-01-02 | Nutrition & Biosciences USA 4, Inc. | Compositions comprising cationic alpha-1,6-glucan derivative and alpha-1,3-glucan |
| EP4447917A1 (en) | 2021-12-16 | 2024-10-23 | Nutrition & Biosciences USA 4, Inc. | Compositions comprising cationic alpha-glucan ethers in aqueous polar organic solvents |
| JP2025523007A (ja) | 2022-07-11 | 2025-07-17 | ニュートリション・アンド・バイオサイエンシーズ・ユーエスエー・フォー,インコーポレイテッド | 両親媒性グルカンエステル誘導体 |
| CN120225168A (zh) | 2022-10-14 | 2025-06-27 | 营养与生物科学美国第四公司 | 包含水、阳离子α-1,6-葡聚糖醚和有机溶剂的组合物 |
| WO2024129951A1 (en) | 2022-12-16 | 2024-06-20 | Nutrition & Biosciences USA 4, Inc. | Esterification of alpha-glucan comprising alpha-1,6 glycosidic linkages |
| WO2024228945A1 (en) | 2023-05-03 | 2024-11-07 | Nutrition & Biosciences USA 4, Inc. | Controlling bacterial cell adhesion with alpha-glucan comprising alpha-1,6 glycosidic linkages |
| WO2025072416A1 (en) | 2023-09-29 | 2025-04-03 | Nutrition & Biosciences USA 4, Inc. | Polysaccharide derivatives |
| WO2025072417A1 (en) | 2023-09-29 | 2025-04-03 | Nutrition & Biosciences USA 4, Inc. | Polysaccharide derivatives |
| WO2025072419A1 (en) | 2023-09-29 | 2025-04-03 | Nutrition & Biosciences Usa 1, Llc | Crosslinked alpha-glucan derivatives |
| WO2025117349A1 (en) | 2023-11-28 | 2025-06-05 | Nutrition & Biosciences USA 4, Inc. | Esterification of alpha-glucan comprising alpha-1,6 glycosidic linkages |
| WO2025199079A1 (en) | 2024-03-20 | 2025-09-25 | Nutrition & Biosciences USA 4, Inc. | Esterification of alpha-glucan comprising alpha-1,6 glycosidic linkages |
Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS58109410A (ja) * | 1981-12-24 | 1983-06-29 | Lion Corp | 口腔用組成物 |
| EP0321180A1 (en) * | 1987-12-17 | 1989-06-21 | Lion Corporation | Oral compositions |
| JPH0413630A (ja) * | 1990-05-01 | 1992-01-17 | Ogawa Koryo Kk | う蝕防止剤 |
| JP2003201246A (ja) * | 2001-10-26 | 2003-07-18 | Herb Road Co | 抗炎症剤及びそれを含む飲食品 |
Family Cites Families (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA1090706A (en) * | 1976-06-30 | 1980-12-02 | Jordan B. Barth | Stable mouthwash containing sodium bicarbonate |
| JPS58134013A (ja) * | 1982-02-04 | 1983-08-10 | Lion Corp | 口臭除去用組成物 |
| JPS6136213A (ja) * | 1984-07-27 | 1986-02-20 | Rooto Seiyaku Kk | 口腔用組成物 |
| US5043154A (en) * | 1987-01-30 | 1991-08-27 | Colgate-Palmolive Co. | Antibacterial, antiplaque, anticalculus oral composition |
| US5288480A (en) * | 1987-01-30 | 1994-02-22 | Colgate-Palmolive Co. | Antiplaque antibacterial oral composition |
| US5225441A (en) * | 1987-06-18 | 1993-07-06 | Block Drug Company, Inc. | Treatment of periodontal disease |
| EG19074A (en) * | 1988-12-29 | 1996-03-31 | Colgate Palmolive Co | Antibacterial antiplaque oral composition |
| EP0480077B1 (fr) * | 1990-10-06 | 1994-09-14 | Societe Des Produits Nestle S.A. | Procédé d'obtention d'acide carnosique |
| JPH07583B2 (ja) * | 1990-11-21 | 1995-01-11 | 北海道糖業株式会社 | 水溶性五環性トリテルペン包接化合物及びその製造方法並びにそれを利用した食品、飲料、口腔用組成物 |
| GB9117140D0 (en) * | 1991-08-08 | 1991-09-25 | Unilever Plc | Treatment of periodontitis |
| PT767654E (pt) * | 1994-07-25 | 2003-04-30 | Warner Lambert Co | Dentifrico antisseptico |
| EP0901366B1 (en) * | 1996-02-08 | 2002-04-17 | Warner-Lambert Company | Anticalculus dentifrice containing highly soluble pyrophosphate |
| US6248309B1 (en) * | 1997-04-04 | 2001-06-19 | Optiva Corporation | Gums containing antimicrobial agents |
| DE10062770A1 (de) * | 2000-12-15 | 2002-07-25 | Haarmann & Reimer Gmbh | Verwendung von Antioxidantien für Mittel zur Bekämpfung von Mundgeruch |
| KR100437574B1 (ko) * | 2001-01-29 | 2004-06-26 | 애드윈코리아 주식회사 | 여드름 예방 및 개선용 화장료 조성물이 코팅된 부직포 |
| NZ527902A (en) * | 2001-03-02 | 2005-06-24 | Kalsec Inc | Labiatae herb extracts and hop extracts for extending the color life and inhibiting the growth of microorganisms in fresh meat, fish and poultry |
| GB0303678D0 (en) * | 2003-02-18 | 2003-03-19 | Quest Int | Improvements in or relating to flavour compositions |
| JP2004352621A (ja) * | 2003-05-27 | 2004-12-16 | Inabata Koryo Kk | 消臭剤及び該消臭剤を含有する口腔用組成物、食品組成物並びに消臭剤組成物 |
-
2005
- 2005-10-24 US US11/256,861 patent/US20060134025A1/en not_active Abandoned
- 2005-11-28 DE DE602005019461T patent/DE602005019461D1/de not_active Expired - Lifetime
- 2005-11-28 PL PL05852367T patent/PL1824566T3/pl unknown
- 2005-11-28 CA CA2590223A patent/CA2590223C/en not_active Expired - Fee Related
- 2005-11-28 RU RU2007127313/15A patent/RU2388456C2/ru not_active IP Right Cessation
- 2005-11-28 WO PCT/US2005/043063 patent/WO2006065522A2/en not_active Ceased
- 2005-11-28 MX MX2007007249A patent/MX2007007249A/es active IP Right Grant
- 2005-11-28 AU AU2005316919A patent/AU2005316919B2/en not_active Ceased
- 2005-11-28 AT AT05852367T patent/ATE457781T1/de not_active IP Right Cessation
- 2005-11-28 DK DK05852367.1T patent/DK1824566T3/da active
- 2005-11-28 BR BRPI0519925A patent/BRPI0519925B1/pt not_active IP Right Cessation
- 2005-11-28 ES ES05852367T patent/ES2340054T3/es not_active Expired - Lifetime
- 2005-11-28 EP EP05852367A patent/EP1824566B1/en not_active Expired - Lifetime
- 2005-12-15 MY MYPI20055902A patent/MY148458A/en unknown
- 2005-12-16 TW TW094144587A patent/TWI399221B/zh not_active IP Right Cessation
- 2005-12-16 AR ARP050105324A patent/AR052057A1/es active IP Right Grant
Patent Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS58109410A (ja) * | 1981-12-24 | 1983-06-29 | Lion Corp | 口腔用組成物 |
| EP0321180A1 (en) * | 1987-12-17 | 1989-06-21 | Lion Corporation | Oral compositions |
| JPH0413630A (ja) * | 1990-05-01 | 1992-01-17 | Ogawa Koryo Kk | う蝕防止剤 |
| JP2003201246A (ja) * | 2001-10-26 | 2003-07-18 | Herb Road Co | 抗炎症剤及びそれを含む飲食品 |
Also Published As
| Publication number | Publication date |
|---|---|
| CA2590223C (en) | 2013-07-02 |
| DK1824566T3 (da) | 2010-05-17 |
| PL1824566T3 (pl) | 2010-07-30 |
| RU2388456C2 (ru) | 2010-05-10 |
| BRPI0519925B1 (pt) | 2015-12-15 |
| ATE457781T1 (de) | 2010-03-15 |
| US20060134025A1 (en) | 2006-06-22 |
| MY148458A (en) | 2013-04-30 |
| AU2005316919A1 (en) | 2006-06-22 |
| CA2590223A1 (en) | 2006-06-22 |
| ES2340054T3 (es) | 2010-05-28 |
| TW200637605A (en) | 2006-11-01 |
| AR052057A1 (es) | 2007-02-28 |
| AU2005316919B2 (en) | 2011-06-23 |
| EP1824566A2 (en) | 2007-08-29 |
| EP1824566B1 (en) | 2010-02-17 |
| BRPI0519925A2 (pt) | 2009-08-11 |
| HK1107041A1 (zh) | 2008-03-28 |
| MX2007007249A (es) | 2007-07-11 |
| RU2007127313A (ru) | 2009-01-27 |
| DE602005019461D1 (de) | 2010-04-01 |
| WO2006065522A3 (en) | 2006-08-24 |
| WO2006065522A2 (en) | 2006-06-22 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| TWI399221B (zh) | 含有迷迭香萃取物之口腔組成物及相關方法 | |
| US11369553B2 (en) | Therapeutic oral composition | |
| TWI399217B (zh) | 含木糖醇之抗齲齒口腔護理組合物 | |
| TWI382852B (zh) | 一種口腔保健用磷酸鈣複合物及其製法與組合物 | |
| CN103025266B (zh) | 与牙刷递送装置一起使用的漱口水制剂 | |
| RU2700002C2 (ru) | Композиции для ухода за полостью рта с высоким содержанием воды и высоким уровнем защиты от микроорганизмов | |
| CN104066417B (zh) | 包含异丁基厚朴酚的口腔护理组合物 | |
| CN101115531B (zh) | 含有迷迭香提取物的口腔组合物以及相关方法 | |
| HK1107041B (zh) | 含有迷迭香屬萃取物的口服組分及相關方法 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MM4A | Annulment or lapse of patent due to non-payment of fees |